0001558370-24-008490.txt : 20240520 0001558370-24-008490.hdr.sgml : 20240520 20240520171103 ACCESSION NUMBER: 0001558370-24-008490 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XCel Brands, Inc. CENTRAL INDEX KEY: 0001083220 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 760307819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37527 FILM NUMBER: 24965657 BUSINESS ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (347) 727-2474 MAIL ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: NETFABRIC HOLDINGS, INC DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: HOUSTON OPERATING CO DATE OF NAME CHANGE: 19990402 10-Q 1 xelb-20240331x10q.htm 10-Q
0.310.2920374920196331940001083220--12-312024Q1false002345211719795053P6YP4Y1M17DP4Y6MP25Y0001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMemberxelb:BusinessVentureAgreementMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-11-012023-11-300001083220xelb:HalstonBrandMembersrt:MinimumMember2023-05-152023-05-150001083220xelb:HalstonBrandMembersrt:MaximumMember2023-05-152023-05-150001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-312022-05-3100010832202023-01-012023-12-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMemberxelb:BusinessVentureAgreementMember2024-04-122024-04-120001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-122024-04-120001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-300001083220us-gaap:WarrantMember2023-01-012023-12-310001083220xelb:LoriGoldsteinBrandMember2021-04-012021-04-0100010832202024-02-162024-02-160001083220xelb:LoriGoldsteinBrandMember2024-01-012024-03-310001083220xelb:LoriGoldsteinBrandMember2023-01-012023-12-310001083220xelb:LoriGoldsteinBrandMember2022-01-012022-12-310001083220xelb:Lease1113BroadwayMember2024-01-262024-01-260001083220xelb:Lease530SeventhAvenueMember2024-02-292024-02-290001083220xelb:Lease1113BroadwayMember2024-01-012024-03-310001083220xelb:HalstonBrandMember2023-05-152023-05-150001083220xelb:HilcoGlobalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2024-01-012024-03-310001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2024-01-012024-03-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001083220xelb:ConsultantsMember2023-01-012023-03-310001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2024-01-012024-03-310001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2024-03-310001083220us-gaap:NoncontrollingInterestMember2024-03-310001083220us-gaap:AdditionalPaidInCapitalMember2024-03-310001083220us-gaap:RetainedEarningsMember2023-12-310001083220us-gaap:NoncontrollingInterestMember2023-12-310001083220us-gaap:AdditionalPaidInCapitalMember2023-12-310001083220us-gaap:RetainedEarningsMember2023-03-310001083220us-gaap:NoncontrollingInterestMember2023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-03-310001083220us-gaap:RetainedEarningsMember2022-12-310001083220us-gaap:NoncontrollingInterestMember2022-12-310001083220us-gaap:AdditionalPaidInCapitalMember2022-12-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001083220xelb:ConsultantsMember2024-01-012024-03-310001083220us-gaap:CommonStockMember2024-03-310001083220us-gaap:CommonStockMember2023-12-310001083220us-gaap:CommonStockMember2023-03-310001083220us-gaap:CommonStockMember2022-12-310001083220us-gaap:PrivatePlacementMember2024-03-140001083220us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMember2023-12-310001083220us-gaap:EmployeeStockOptionMember2024-03-310001083220us-gaap:EmployeeStockOptionMember2023-12-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-152023-05-150001083220xelb:ConsultantMember2024-01-122024-01-120001083220xelb:IMTopcoLLCMemberxelb:YearEndingDecember312025Memberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberxelb:TwelveMonthPeriodEndingMarch312025Memberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-03-310001083220srt:MaximumMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2022-05-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2024-01-012024-03-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:HalstonBrandMember2024-01-012024-03-310001083220us-gaap:LicenseMember2024-01-012024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220us-gaap:ProductMember2023-01-012023-03-310001083220us-gaap:LicenseMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2024-01-012024-03-310001083220us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001083220us-gaap:RetainedEarningsMember2023-01-012023-03-310001083220us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001083220xelb:PublicOfferingAndPrivatePlacementMember2024-03-152024-03-1500010832202024-03-012024-03-310001083220us-gaap:CommonStockMemberxelb:PublicOfferingAndPrivatePlacementMember2024-01-012024-03-310001083220us-gaap:AdditionalPaidInCapitalMemberxelb:PublicOfferingAndPrivatePlacementMember2024-01-012024-03-310001083220xelb:PublicOfferingAndPrivatePlacementMember2024-01-012024-03-310001083220us-gaap:PrivatePlacementMember2024-03-142024-03-140001083220xelb:PublicOfferingMember2024-03-192024-03-190001083220xelb:OrmeLiveMember2023-12-012023-12-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2022-05-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-11-012023-11-300001083220xelb:OrmeLiveMember2024-03-310001083220xelb:IMTopcoLLCMember2024-03-310001083220xelb:OrmeLiveMember2023-12-310001083220xelb:IMTopcoLLCMember2022-05-310001083220xelb:IMTopcoLLCMember2023-07-012023-09-300001083220xelb:OrmeLiveMember2024-01-012024-03-310001083220xelb:Lease1113BroadwayMemberxelb:RightOfUseAssetMember2024-02-292024-02-290001083220xelb:Lease1113BroadwayMemberus-gaap:LeaseholdImprovementsMember2024-01-012024-03-310001083220xelb:IMTopcoLLCMember2024-01-012024-03-310001083220xelb:IMTopcoLLCMember2023-01-012023-03-310001083220us-gaap:TrademarksMember2024-03-310001083220us-gaap:IntellectualPropertyMember2024-03-310001083220us-gaap:TrademarksMember2023-12-310001083220us-gaap:IntellectualPropertyMember2023-12-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2024-03-310001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-270001083220us-gaap:RestrictedStockMember2024-01-012024-03-310001083220us-gaap:EmployeeStockOptionMember2024-03-310001083220us-gaap:SwapMember2023-10-190001083220xelb:IsraelDiscountBankOfNewYorkMemberus-gaap:SwapMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-190001083220xelb:HalstonBrandMember2024-03-310001083220xelb:HalstonBrandMember2023-12-310001083220xelb:NewLoanAndSecurityAgreementMember2023-10-192023-10-190001083220xelb:NewLoanAndSecurityAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-190001083220xelb:NewLoanAndSecurityAgreementMember2024-03-310001083220xelb:NewLoanAndSecurityAgreementMember2023-10-190001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:HalstonBrandMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220xelb:PublicOfferingMember2024-03-190001083220xelb:PublicOfferingMember2024-03-150001083220us-gaap:CommonStockMemberxelb:PublicOfferingAndPrivatePlacementMember2024-03-310001083220us-gaap:RestrictedStockMember2024-03-310001083220srt:ExecutiveVicePresidentMemberxelb:PublicOfferingMember2024-03-190001083220srt:DirectorMemberxelb:PublicOfferingMember2024-03-190001083220srt:ChiefExecutiveOfficerMemberxelb:PublicOfferingMember2024-03-190001083220xelb:PublicOfferingAndPrivatePlacementMember2024-03-150001083220xelb:AgreementsMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:ExecutiveVicePresidentMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:DirectorMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:ChiefExecutiveOfficerMemberus-gaap:PrivatePlacementMember2024-03-140001083220us-gaap:RestrictedStockMember2023-12-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2021Member2024-03-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2011Member2024-03-310001083220xelb:EquityIncentivePlan2021Member2024-03-310001083220us-gaap:WarrantMember2024-03-310001083220us-gaap:WarrantMember2023-12-310001083220us-gaap:WarrantMember2024-03-190001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-1500010832202022-12-3100010832202023-03-310001083220xelb:LoriGoldsteinBrandMember2023-12-310001083220us-gaap:WarrantMember2024-01-012024-03-310001083220us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001083220us-gaap:WarrantMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:WarrantMember2024-01-012024-03-310001083220us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001083220us-gaap:CommonStockMember2024-01-012024-03-310001083220us-gaap:WarrantMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:CommonStockMember2023-01-012023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100010832202023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-12-3100010832202024-03-3100010832202023-12-3100010832202024-05-0100010832202024-01-012024-03-31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purexelb:item

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

or

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

For the transition period from ___ to ___

Commission File Number: 001-37527

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

76-0307819

(State or Other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

 

550 Seventh Avenue, 11th Floor, New York, NY 10018

 

 

(Address of Principal Executive Offices)

 

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, $0.001 par value per share

XELB

NASDAQ Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes         No   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes       No   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company   

 

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes       No   

As of May 1, 2024, there were 23,492,117 shares of common stock, $.001 par value per share, of the issuer outstanding.

XCEL BRANDS, INC.

INDEX

a

Page

PART I - FINANCIAL INFORMATION

3

Item 1.

Financial Statements

3

Unaudited Condensed Consolidated Balance Sheets

3

Unaudited Condensed Consolidated Statements of Operations

4

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

5

Unaudited Condensed Consolidated Statements of Cash Flows

6

Notes to Unaudited Condensed Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

22

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

29

Item 4.

Controls and Procedures

30

PART II - OTHER INFORMATION

31

Item 1.

Legal Proceedings

31

Item 1A.

Risk Factors

31

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

31

Item 3.

Defaults Upon Senior Securities

31

Item 4.

Mine Safety Disclosures

32

Item 5.

Other Information

32

Item 6.

Exhibits

32

Signatures

32

2

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

    

March 31, 2024

    

December 31, 2023

(Unaudited)

(Note 1)

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

1,552

$

2,998

Accounts receivable, net of allowances for credit losses of $75 at March 31, 2024 and December 31, 2023

 

3,603

 

3,454

Inventory

 

445

 

453

Prepaid expenses and other current assets

 

471

 

398

Total current assets

 

6,071

 

7,303

Non-current Assets:

Property and equipment, net

 

133

 

634

Operating lease right-of-use assets

2,535

4,453

Trademarks and other intangibles, net

 

39,986

 

41,520

Equity method investment in IM Topco, LLC

17,070

17,585

Other assets

 

969

 

165

Total non-current assets

 

60,693

 

64,357

Total Assets

$

66,764

$

71,660

Liabilities and Stockholders' Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable, accrued expenses and other current liabilities

$

1,918

$

2,236

Deferred revenue

 

889

 

889

Accrued income taxes payable

372

372

Current portion of operating lease obligations

1,278

1,258

Current portion of long-term debt

 

1,000

 

750

Current portion of contingent obligation

 

723

 

964

Total current liabilities

 

6,180

 

6,469

Long-Term Liabilities:

 

  

 

  

Deferred revenue

3,333

3,556

Long-term portion of operating lease obligations

3,694

4,021

Long-term debt, net, less current portion

 

3,747

 

3,971

Long-term portion of contingent obligation

5,432

5,432

Other long-term liabilities

 

506

 

40

Total long-term liabilities

 

16,712

 

17,020

Total Liabilities

 

22,892

 

23,489

Commitments and Contingencies

 

  

 

  

Stockholders' Equity:

 

  

 

  

Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding

 

 

Common stock, $.001 par value, 50,000,000 shares authorized, and 23,452,117 and 19,795,053 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively

 

23

 

20

Paid-in capital

 

105,904

 

103,861

Accumulated deficit

 

(60,143)

 

(53,849)

Total Xcel Brands, Inc. stockholders' equity

 

45,784

 

50,032

Noncontrolling interest

(1,912)

(1,861)

Total Stockholders' Equity

 

43,872

 

48,171

Total Liabilities and Stockholders' Equity

$

66,764

$

71,660

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

3

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

For the Three Months Ended

March 31, 

    

2024

    

2023

Revenues

  

 

  

Net licensing revenue

$

2,184

$

2,222

Net sales

 

 

3,828

Net revenue

 

2,184

 

6,050

Cost of goods sold

 

 

2,693

Gross profit

 

2,184

 

3,357

Direct operating costs and expenses

 

  

 

  

Salaries, benefits and employment taxes

 

1,933

 

3,465

Other selling, general and administrative expenses

 

2,029

 

3,493

Total direct operating costs and expenses

 

3,962

 

6,958

Operating loss before other operating costs and expenses

(1,778)

(3,601)

Other operating costs and expenses

Depreciation and amortization

 

1,589

 

1,797

Asset impairment charges

2,295

Loss from equity method investments

533

515

Operating loss

 

(6,195)

 

(5,913)

Interest and finance (income) expense

 

  

 

  

Interest expense - term loan debt

 

146

 

Other interest and finance charges (income), net

 

4

 

25

Total interest and finance (income) expense

 

150

 

25

Loss before income taxes

 

(6,345)

 

(5,938)

Income tax benefit

 

 

Net loss

(6,345)

(5,938)

Net loss attributable to noncontrolling interest

(51)

(295)

Net loss attributable to Xcel Brands, Inc. stockholders

$

(6,294)

$

(5,643)

Loss per common share attributable to Xcel Brands, Inc. stockholders:

 

  

 

  

Basic and diluted net loss per share

$

(0.31)

$

(0.29)

Weighted average number of common shares outstanding:

 

  

 

  

Basic and diluted weighted average common shares outstanding

 

20,374,920

 

19,633,194

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

4

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

Xcel Brands, Inc. Stockholders

Common Stock

Number of

Paid-In

Accumulated

Noncontrolling

    

Shares

    

Amount

    

Capital

    

Deficit

    

Interest

Total

Balance as of December 31, 2022

 

19,624,860

$

20

$

103,592

$

(32,797)

$

(676)

$

70,139

Compensation expense related to stock options and restricted stock

51

51

Shares issued to consultant in connection with stock grant

8,334

6

6

Net loss

 

 

 

 

(5,643)

(295)

 

(5,938)

Balance as of March 31, 2023

 

19,633,194

$

20

$

103,649

$

(38,440)

$

(971)

$

64,258

Balance as of December 31, 2023

 

19,795,053

$

20

$

103,861

$

(53,849)

$

(1,861)

$

48,171

Compensation expense related to stock options and restricted stock

36

36

Contra-revenue related to warrants held by licensee

10

10

Shares issued to consultant in connection with stock grant

 

78,000

 

 

98

 

 

 

98

Shares issued in connection with public offering and private placement transactions, net of transaction costs

3,579,064

3

1,899

1,902

Net loss

 

 

 

 

(6,294)

(51)

 

(6,345)

Balance as of March 31, 2024

 

23,452,117

$

23

$

105,904

$

(60,143)

$

(1,912)

$

43,872

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

5

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

For the Three Months Ended March 31, 

    

2024

    

2023

Cash flows from operating activities

 

  

 

  

Net loss

$

(6,345)

$

(5,938)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

Depreciation and amortization expense

 

1,589

 

1,797

Asset impairment charges

 

2,295

 

Amortization of deferred finance costs included in interest expense

 

26

 

Stock-based compensation and cost of licensee warrants

 

144

 

57

Undistributed proportional share of net loss of equity method investees

533

515

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(149)

 

(859)

Inventory

 

8

 

(254)

Prepaid expenses and other current and non-current assets

 

(156)

 

425

Deferred revenue

(223)

240

Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities

 

(560)

 

1,156

Lease-related assets and liabilities

(237)

(54)

Other long-term liabilities

 

466

 

Net cash used in operating activities

 

(2,609)

 

(2,915)

Cash flows from investing activities

 

  

 

  

Purchase of property and equipment

 

 

(81)

Net cash used in investing activities

 

 

(81)

Cash flows from financing activities

 

  

 

  

Proceeds from public offering and private placement transactions, net of transaction costs

1,902

Net cash provided by financing activities

 

1,902

 

Net decrease in cash, cash equivalents, and restricted cash

 

(707)

 

(2,996)

Cash, cash equivalents, and restricted cash at beginning of period

2,998

4,608

Cash, cash equivalents, and restricted cash at end of period

$

2,291

$

1,612

Reconciliation to amounts on consolidated balance sheets:

 

  

 

  

Cash and cash equivalents

$

1,552

$

1,612

Restricted cash (reported in other non-current assets)

 

739

 

Total cash, cash equivalents, and restricted cash

$

2,291

$

1,612

Supplemental disclosure of cash flow information:

 

  

 

  

Cash paid during the period for interest

$

119

$

Cash paid during the period for income taxes

$

$

16

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

6

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024.

The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands.

The Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its 30% ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting.
The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch by the end of May 2024.

The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.

The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.

7

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. The Company had working capital (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in common stock) of approximately $2.1 million as of March 31, 2024. The Company’s unrestricted cash and cash equivalents were approximately $1.6 million as of March 31, 2024. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity.

Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated.

2.      Investments in Unconsolidated Affiliates and Variable Interest Entities  

Investment in IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

8

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

The Company accounts for its 30% interest in the ongoing operations of IM Topco as other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective percentage interests.

Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million related to its investment in IM Topco for each of the three-month periods ended March 31, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for both of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal Xcel’s share of amortization expense.

Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows:

    

For the three months ended

March 31,

($ in thousands)

2024

2023

Revenues

$

2,752

$

3,346

Gross profit

2,752

3,346

Loss from continuing operations

(437)

(143)

Net loss

(437)

(143)

Refer to Notes 10, 11, and 12 for other information regarding the Company’s ongoing relationship with IM Topco.

Investment in Orme Live, Inc.

In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s condensed consolidated balance sheets.

The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three months ended March 31, 2024 was a loss of approximately $0.02 million.

9

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

March 31, 2024

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

28,950

 

39,930

Copyrights and other intellectual property

 

8 years

 

429

 

373

 

56

Total

$

69,309

$

29,323

$

39,986

    

Weighted

    

    

    

 

Average

 

December 31, 2023

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

27,431

 

41,449

Copyrights and other intellectual property

 

8 years

 

429

 

358

 

71

Total

 

  

$

69,309

$

27,789

$

41,520

Amortization expense for intangible assets was approximately $1.53 million for the three-month period ended March 31, 2024 (the "current quarter") and approximately $1.54 million for the three-month period ended March 31, 2023 (the "prior year quarter").

4.      Significant Contracts and Concentrations

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.61 million and $1.52 million for the current quarter and prior year quarter, respectively, representing approximately 59% and 25% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.

10

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

As of March 31, 2024 and December 31, 2023, the Company had receivables from Qurate of $1.3 million and $1.5 million, respectively, representing approximately 37% and 43% of the Company’s total net accounts receivable, respectively.

Halston Master License

On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.2 million and $4.4 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. As of December 31, 2023, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.5 million was classified as a long-term liability. As of March 31, 2024, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.3 million was classified as a long-term liability.

The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 4.13 years. Net licensing revenue recognized from the Halston Master License was $0.6 million for the current quarter, representing approximately 30% of the Company’s total net revenue for the current quarter.

5. Leases

The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.

Lease expense (net of sublease income) included in selling, general and administrative expenses on the Company’s condensed consolidated statements of operations was approximately $0.2 million and $0.4 million for the current quarter and prior year quarter, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter.

1333 Broadway

The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property.

11

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized a non-cash impairment charge of approximately $1.9 million effective February 29, 2024 (which was determined to be the date of a fundamental change to the use of the 1333 Broadway premises) related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the current quarter related to leasehold improvement assets at this location.

As of March 31, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.58 years, and the lease liability recorded on the Company’s condensed consolidated balance sheet is measured using a discount rate of 6.25%.

550 Seventh Avenue

Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year. As of March 31, 2024, no right-of-use asset or lease liability was recorded in the Company’s condensed consolidated balance sheet related to this lease, as the lease had not yet commenced.

Future Lease Obligations

As of March 31, 2024, the maturities of lease obligations were as follows:

Amount

Year

    

(in thousands)

2024 (April 1 through December 31)

$

1,164

2025

1,552

2026

 

1,552

2027

 

1,294

Total lease payments

5,562

Less: Discount

590

Present value of lease liabilities

4,972

Current portion of lease liabilities

1,278

Non-current portion of lease liabilities

$

3,694

6. Debt

The Company’s net carrying amount of debt was comprised of the following:

March 31, 

December 31, 

($ in thousands)

    

2024

    

2023

Term loan debt

$

5,000

$

5,000

Unamortized deferred finance costs related to term loan debt

 

(253)

 

(279)

Total

 

4,747

 

4,721

Current portion of debt

 

1,000

 

750

Long-term debt

$

3,747

$

3,971

12

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.

In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

As of March 31, 2024, the aggregate remaining principal payments under the term loan were as follows:

Amount of

($ in thousands)

 

Principal

Year Ending December 31, 

    

Payment

2024 (April 1 through December 31)

$

750

2025

 

1,000

2026

1,000

2027

1,000

2028

 

1,250

Total

$

5,000

Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of March 31, 2024 and December 31, 2023.

For the current quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.15 million, reflecting an effective interest rate of approximately 11.6%.

The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio,

13

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

7. Stockholders’ Equity

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense

14

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized for all forms of stock-based compensation was approximately $0.13 million and $0.06 million for the current quarter and prior year quarter, respectively. For both periods, substantially all of the expense was related to directors and consultants, and was recorded as operating costs within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations.

Stock Options

A summary of the Company’s stock options activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2024

 

5,148,540

$

2.03

 

4.26

$

Granted

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(259,500)

 

4.21

 

  

 

  

Outstanding at March 31, 2024, and expected to vest

 

4,889,040

$

1.91

 

4.24

$

Exercisable at March 31, 2024

 

1,139,040

$

2.58

 

1.78

$

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.03 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2024 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.97 years.

A summary of the Company’s non-vested stock options activity for the current quarter is as follows:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2024

 

3,750,000

$

0.05

Granted

 

 

Vested

 

Forfeited or Canceled

 

 

Balance at March 31, 2024

 

3,750,000

$

0.05

15

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Stock Awards

A summary of the Company’s restricted stock activity for the current quarter is as follows:  

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2024

 

333,333

$

3.69

Granted

 

78,000

 

1.25

Vested

 

(78,000)

 

1.25

Expired/Forfeited

 

 

Outstanding at March 31, 2024

 

333,333

$

3.69

On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which shares vested immediately.

Compensation expense related to stock awards was approximately $0.11 million for the current quarter and approximately $0.03 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2024 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 0.96 years.

Restricted Stock Units

There were no restricted stock units outstanding as of March 31, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At March 31, 2024, there were 3,025,941 shares of common stock available for future award grants under the 2021 Plan.

Shares Reserved for Issuance

As of March 31, 2024, there were 8,031,046 shares of common stock reserved for issuance, including 4,511,755 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,025,941 shares available for issuance under the 2021 Plan.

16

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Warrants

A summary of the Company’s warrants activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2024

 

1,116,065

$

1.67

 

8.46

$

Issued

 

182,952

 

0.81

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at March 31, 2024

 

1,299,017

$

1.55

 

7.75

$

Exercisable at March 31, 2024

 

116,065

$

3.15

 

0.30

$

Warrants issued during the current quarter were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was no compensation expense recognized during the current quarter related to these warrants.

In connection with the entrance into the Halston Master License (see Note 4), the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the current quarter was approximately $0.01 million. As of March 31, 2024, no portion of this warrant had vested.

Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in the current quarter or prior year quarter.

8.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

17

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the three months ended March 31, 2024 and 2023:

Three Months Ended

March 31, 

    

2024

    

2023

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(6,294)

$

(5,643)

Denominator:

Basic weighted average number of shares outstanding

20,374,920

 

19,633,194

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

20,374,920

 

19,633,194

Basic net loss per share

$

(0.31)

$

(0.29)

Diluted net loss per share

$

(0.31)

$

(0.29)

As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share for such periods.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

Three Months Ended

March 31, 

    

2024

    

2023

Stock options

4,889,040

5,368,780

Warrants

1,299,017

116,065

Total

6,188,057

 

5,484,845

 

9.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

18

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

10.    Related Party Transactions

IM Topco, LLC

As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

Service Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.

In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.

The Company recognized service fee income related to this agreement of $37,500 and $75,000 for the current quarter and prior year quarter, respectively.

License Agreement

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the prior year quarter, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. No amounts were paid to IM Topco during the current quarter, and as of March 31, 2024, the remaining payments due totaled $375,000.

Financing Transactions

Public Offering and Private Placement Transactions

In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 7 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and

19

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

11.    Commitments and Contingencies

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).

No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Legal Matters

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

20

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment.

On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all.

As of the filing date of this Quarterly Report on Form 10-Q, there have been no definitive agreements or terms agreed to by the parties, and it is not certain when or if an agreement will be executed.

12.    Subsequent Events

IM Topco

On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 (and as subsequently amended) membership purchase agreement and the related business venture agreement. Under these amendments, the parties agreed to the following:

The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.
If IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco by October 10, 2024 under the second amendment (which totaled $375,000 as of December 31, 2023 and March 31, 2024). In April 2024, Xcel paid $100,000 of this amount to WHP.
On and after January 1, 2026, WHP shall receive 50% of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to $1.0 million.  

21

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Factors section of our Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on April 19, 2024. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as one thing. Currently, the Company’s brand portfolio consists of the following:

the Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand, which are wholly owned by the Company.
the Longaberger Brand, which we manage through our 50% ownership interest in Longaberger Licensing, LLC, and the CB Brand, which is a co-owned brand between Xcel and Christie Brinkley; and
the Isaac Mizrahi Brand, in which we hold a 30% noncontrolling interest and continue to contribute to the operations of the brand through a service agreement.

We also own a 30% interest in ORME Live Inc., a short-form video and social commerce marketplace that launched in the first quarter of 2024.

Xcel continues to pioneer a true omni-channel and social commerce sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Our brands have generated over $5 billion in retail sales via live streaming in interactive television and digital channels alone, and our brands collectively reach over 5 million social media followers through Facebook, Instagram, and TikTok. All of the followers may not be unique followers, as many followers may follow multiple brands and follow our brands on multiple platforms.

Our objective is to build a diversified portfolio of lifestyle consumer products brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

distribution and/or licensing of our brands for sale through interactive television (e.g., QVC, HSN, The Shopping Channel, JTV, etc.);
licensing of our brands to retailers that sell to the end consumer;
direct-to-consumer distribution of our brands through e-commerce and live streaming;
licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels; and

22

acquiring additional consumer brands and integrating them into our operating platform, and leveraging our operating infrastructure and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

our management team, including our officers’ and directors’ experience in, and relationships within the industry;
our deep knowledge, expertise, and proprietary technology in live streaming and social commerce;
our design, sales, marketing, and technology platform that enables us to design trend-right product; and
our significant media and internet presence.

Summary of Operating Results

Three months ended March 31, 2024 (the “current quarter”) compared with the three months ended March 31, 2023 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased approximately $3.9 million to $2.2 million from $6.1 million for the prior year quarter. This decline was almost entirely attributable to the decrease in net product sales to zero, due to the exit from our wholesale apparel and fine jewelry sales operations and outsourcing of our Longaberger business as part of the restructuring and transformation of our business operating model in 2023. Net licensing revenue was approximately $2.2 million in both the current quarter and prior year quarter, and with a decrease of less than 2% was essentially flat year-over-year.

Cost of Goods Sold

Current quarter cost of goods sold was zero, compared with $2.7 million for the prior year quarter. This was driven by the aforementioned exit from our wholesale and direct-to-consumer operations as part of the 2023 business model restructuring.

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $3.0 million from $7.0 million in the prior year quarter to $4.0 million in the current quarter. This decrease was primarily attributable to the 2023 restructuring and transformation of our business operating model, which included reductions in staffing levels as well as related reductions in other overhead costs.

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense was approximately $1.6 million and $1.8 million in the current quarter and prior year quarter, respectively.

We recognized equity method losses related to our equity investments in unconsolidated affiliates (IM Topco, LLC and Orme Live Inc.) of $0.53 million and $0.52 million for the current quarter and prior year quarter, respectively, due to the operations of those businesses and the distribution provisions applicable to each.

23

During the current quarter, we recognized asset impairment charges of $2.3 million related to our exit from and sublease of our offices at 1333 Broadway, of which $1.9 million related to the operating lease right-of-use asset and $0.4 million related to leasehold improvements at that location.

Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $6.3 million for the current quarter, compared with a net loss of $5.6 million for the prior year quarter, due to the combination of the factors outlined above.

Non-GAAP Net (Loss) Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $1.8 million, or $0.09 per diluted share (“non-GAAP diluted EPS”), for the current quarter and a non-GAAP net loss of $3.6 million, or $0.18 per diluted share, for the prior year quarter. Non-GAAP net (loss) income is a non-GAAP unaudited term, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders, exclusive of amortization of trademarks, our proportional share of trademark amortization of equity method investees, stock-based compensation and cost of licensee warrants, asset impairment charges, and income taxes. Non-GAAP net income and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(1.6) million for the current quarter, compared with approximately $(3.2) million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders before depreciation and amortization, our proportional share of trademark amortization of equity method investees, interest and finance expenses (including loss on extinguishment of debt, if any), income taxes, other state and local franchise taxes, stock-based compensation and cost of licensee warrants, gains on sales of assets and investments, gain on lease termination, asset impairment charges, and costs associated with restructuring of operations.

Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by

24

these expenses or any other unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:

 

Three Months Ended

March 31, 

($ in thousands)

    

2024

    

2023

Net loss attributable to Xcel Brands, Inc. stockholders

$

(6,294)

$

(5,643)

Amortization of trademarks

 

1,519

 

1,520

Proportional share of trademark amortization of equity method investee

515

515

Stock-based compensation and cost of licensee warrants

 

144

 

57

Asset impairment charges

2,295

Non-GAAP net loss

$

(1,821)

$

(3,551)

The following table is a reconciliation of diluted net loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

Three Months Ended

March 31, 

    

2024

    

2023

Diluted net loss per share

$

(0.31)

$

(0.29)

Amortization of trademarks

 

0.07

 

0.08

Proportional share of trademark amortization of equity method investee

0.03

0.03

Stock-based compensation and cost of licensee warrants

 

0.01

 

0.00

Asset impairment charges

0.11

Non-GAAP diluted EPS

$

(0.09)

$

(0.18)

Non-GAAP weighted average diluted shares

 

20,374,920

 

19,633,194

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

Three Months Ended

March 31, 

($ in thousands)

    

2024

    

2023

Net loss attributable to Xcel Brands, Inc. stockholders

$

(6,294)

$

(5,643)

Asset impairment charges

 

2,295

 

Depreciation and amortization

 

1,589

 

1,797

Proportional share of trademark amortization of equity method investee

515

515

Interest and finance expense

 

150

 

25

State and local franchise taxes

 

12

 

21

Stock-based compensation and cost of licensee warrants

 

144

 

57

Adjusted EBITDA

$

(1,589)

$

(3,228)

Liquidity and Capital Resources

General

As of March 31, 2024 and December 31, 2023, our unrestricted cash and cash equivalents were $1.6 million and $3.0 million, respectively. Restricted cash at March 31, 2024 (included within other assets in the condensed consolidated balance sheet) consisted of $0.7 million of cash deposited with Israel Discount Bank of New York as collateral for a standby letter of credit associated with a real estate lease; there was no restricted cash as of December 31, 2023.

25

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. Our current “licensing plus” operating model is a working capital light business model, and generally does not require material capital expenditures. As of March 31, 2024, we have no significant commitments for future capital expenditures.

Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of operating lease obligations, deferred revenue, and any contingent obligations payable in common stock) was $2.1 million and $2.9 million as of March 31, 2024 and December 31, 2023, respectively.

Liquidity and Management’s Plans  

We incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. These factors, along with our current levels of cash and working capital, raise uncertainties about the Company’s ability to continue as a going concern.

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity.

Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated.

Commentary on the components of our cash flows for the current quarter as compared with the prior year quarter is set forth below.

Operating Activities

Net cash used in operating activities was approximately $2.61 million in the current quarter, compared with approximately $2.92 million in the prior year quarter.

The current quarter net cash used in operating activities was primarily attributable to the combination of the net loss of $(6.35) million plus non-cash items of approximately $4.59 million and the net change in operating assets and liabilities of approximately $(0.85) million. Non-cash items were primarily comprised of asset impairment charges of approximately $2.30 million, $1.59 million of depreciation and amortization, and the $0.53 million undistributed proportional share of net loss of equity method investees. The net change in operating assets and liabilities was primarily comprised of (i) a

26

decrease in deferred revenue of approximately $(0.22) million, mainly related to the Halston Master License agreement, (ii) a decrease in various operating liabilities of $(0.56) million, and (iii) a decrease in lease-related assets and liabilities of $(0.24) million.

The prior year quarter net cash used in operating activities was primarily attributable to the combination of the net loss of $(5.94) million plus non-cash items of approximately $2.37 million and the net change in operating assets and liabilities of approximately $0.65 million. Non-cash items were primarily comprised of $1.80 million of depreciation and amortization and the $0.52 million undistributed proportional share of net loss of an equity method investee. The net change in operating assets and liabilities was primarily comprised of increases in various operating liabilities (including deferred revenue) of approximately $1.40 million, partially offset by an increase in accounts receivable of $(0.86) million.

Investing Activities

There was no net cash used in or provided by investing activities for the current quarter.

Net cash used in investing activities for the prior year quarter consisted of approximately $0.08 million of capital expenditures, primarily related to software.

Financing Activities

Net cash provided by financing activities was $1.90 million, due to the financing transactions described below.

There was no net cash used in or provided by financing activities in the prior year quarter.

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

27

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi brand, we agreed with WHP (the buyer) that, in the event that IM Topco, LLC receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from us up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by us in either cash or equity interests in IM Topco, LLC held by us.

In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. No amount has been recorded in the Company’s condensed consolidated balance sheets related to this contingent obligation.

In April 2024, the Company, WHP, and IM Topco, LLC entered into an amendment to this agreement, such that the purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. Additionally, the parties agreed that if IM Topco, LLC royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco, LLC to WHP, such that Xcel’s ownership interest in IM Topco, LLC would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco, LLC would increase from 70% to 82.5%.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, we agreed to pay the seller additional cash consideration of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and thus $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability. The $0.2 million of additional consideration was paid to the seller during 2023.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Halston brand, C Wonder brand, Lori Goldstein brand, and TowerHill by Christie Brinkley brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business, and the Longaberger brand focuses on home good products, which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

While the 2022 sale of a majority interest in the Isaac Mizrahi brand resulted in a decrease in our revenues, as that brand represented a significant portion of our historical revenues, we are taking actions to replace those revenues in the long-term with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, and additional domestic and international licensing arrangements, and acquiring and collaborating with additional brands, launching the C Wonder by Christian Siriano business on HSN, and the planned May 2024 launch of the TowerHill by Christie Brinkley brand.

28

During 2023, we restructured our business operations by shifting our business from a wholesale/licensing hybrid model into a “licensing plus” business model. These efforts included entering into new structured contractual arrangements with best-in-class business partners in order to more efficiently operate our wholesale and e-commerce businesses and reduce and better manage our exposure to operating risks. These restructuring initiatives, on a go-forward basis, are expected to provide us with approximately $15 million of cost savings on an annualized basis compared to our previous operating model.

Nonetheless, we continue to face a number of headwinds in the current macroeconomic environment. Poor economic and market conditions, including inflation and rising consumer debt levels, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of inflation and/or a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and continue to attract wholesale and direct-to-consumer customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, changes in the prices of supplies, consolidation of retail establishments, and other factors noted in Item 1A of our most recent Annual Report on Form 10-K could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 19, 2024, for a discussion of our critical accounting policies and estimates. During the three months ended March 31, 2024, there were no material changes to our accounting policies.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

29

ITEM 4.    CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2024, the end of the period covered by this report. Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of March 31, 2024, due to the material weakness described below.

The basis for the conclusion that such internal control was ineffective included the following considerations:

The Company was unable to file its Annual Report on Form 10-K within the time specified in SEC rules and forms, due to a failure to obtain audited financial statements of the Company’s investment in an equity method investee. Additional procedures were required for the Company’s audit, which impacted on the resources required to timely file the Company’s Form 10-K.
During the middle of February 2024, our equity method investee engaged an independent audit accounting firm (separate from Marcum, LLP) to conduct its audit. We agreed to pay for all fees of the audit, and on February 23, 2024, paid a retainer to the audit firm, in accordance with the engagement. The audit firm was the same firm which conducted the audit for the year ended December 31, 2022 for the same equity method investee and delivered timely such audited financial statements for such prior audit. However, the audit firm for the equity method investee has not completed the 2023 audit on a timely basis. It was determined their progress was significantly deficient, and there would not be sufficient time to engage a new audit firm to receive timely, audited financial statements of the equity method investee. The determination was made to terminate this firm’s 2023 engagement and have a new firm engaged to provide the 2023 audited financial statements.

Going forward, the Company will arrange for the appointment of a different auditor by the equity method investee and take a more active role in communicating with the auditor of the equity method investee, including assessing progress and timing.

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

30

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein earn-out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment.

On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all.

ITEM 1A.    RISK FACTORS

We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

ITEM 2.   

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the representative were approximately $0.3 million. The purchase of the Private Placement Shares closed on March 19, 2024.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

31

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.    OTHER INFORMATION

None.

ITEM 6.    EXHIBITS

The following exhibits are filed herewith:

31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)

31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)

32.1 Section 1350 Certification (CEO) *

32.2 Section 1350 Certification (CFO) *

101.INS Inline XBRL Instance Document

101.SCH Inline XBRL Taxonomy Extension Schema Document

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 20, 2024

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer

 

 

 

 

By:

/s/ James Haran

 

 

Name: James Haran

 

 

Title: Chief Financial Officer and Vice President

32

EX-31.1 2 xelb-20240331xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert W. D’Loren, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 20, 2024

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer


EX-31.2 3 xelb-20240331xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Haran, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 20, 2024

By:

/s/ James Haran

 

 

Name: James Haran

Title: Chief Financial Officer and Vice President

 

 


EX-32.1 4 xelb-20240331xex32d1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert W. D’Loren, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 20, 2024

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer


EX-32.2 5 xelb-20240331xex32d2.htm EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James Haran, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 20, 2024

By:

/s/ James Haran

 

 

Name: James Haran

 

 

Title: Chief Financial Officer and Vice President


EX-101.SCH 6 xelb-20240331.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Debt and Other Long-term Liabilities - Net Carrying Amount of Debt (Details) (Calc2) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Debt - Net Carrying Amount of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Debt - Xcel Term Loan Remaining Principal Payments (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details) link:presentationLink link:calculationLink link:definitionLink 40205 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Significant Contracts - Qurate Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Significant Contracts - Halson Master License (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Stockholders' Equity - Public Offering and Private Placement Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40704 - Disclosure - Stockholders' Equity - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 40705 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) link:presentationLink link:calculationLink link:definitionLink 40706 - Disclosure - Stockholders' Equity - Stock Awards (Details) link:presentationLink link:calculationLink link:definitionLink 40707 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 40708 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Related Party Transactions - IM Topco, LLC & License Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Related Party Transactions - Financing Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Trademarks and Other Intangibles link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Significant Contracts and Concentrations link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Trademarks and Other Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 xelb-20240331_cal.xml EX-101.CAL EX-101.DEF 8 xelb-20240331_def.xml EX-101.DEF EX-101.LAB 9 xelb-20240331_lab.xml EX-101.LAB EX-101.PRE 10 xelb-20240331_pre.xml EX-101.PRE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2024
May 01, 2024
Document And Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Current Fiscal Year End Date --12-31  
Document Transition Report false  
Entity File Number 001-37527  
Entity Registrant Name XCEL BRANDS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 76-0307819  
Entity Address, Address Line One 550 Seventh Avenue, 11th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10018  
City Area Code 347  
Local Phone Number 727-2474  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol XELB  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   23,492,117
Entity Central Index Key 0001083220  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 1,552 $ 2,998
Accounts receivable, net of allowances for credit losses of $75 at March 31, 2024 and December 31, 2023 3,603 3,454
Inventory 445 453
Prepaid expenses and other current assets 471 398
Total current assets 6,071 7,303
Non-current Assets:    
Property and equipment, net 133 634
Operating lease right-of-use assets 2,535 4,453
Trademarks and other intangibles, net 39,986 41,520
Equity method investment in IM Topco, LLC 17,070 17,585
Other assets 969 165
Total non-current assets 60,693 64,357
Total Assets 66,764 71,660
Current Liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,918 2,236
Deferred revenue 889 889
Accrued income taxes payable 372 372
Current portion of operating lease obligations 1,278 1,258
Current portion of long-term debt 1,000 750
Current portion of contingent obligation 723 964
Total current liabilities 6,180 6,469
Long-Term Liabilities:    
Long-term portion of operating lease obligations 3,694 4,021
Deferred revenue 3,333 3,556
Long-term debt, net, less current portion 3,747 3,971
Long-term portion of contingent obligations 5,432 5,432
Other long-term liabilities 506 40
Total long-term liabilities 16,712 17,020
Total Liabilities 22,892 23,489
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value, 50,000,000 shares authorized, and 23,452,117 and 19,795,053 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 23 20
Paid-in capital 105,904 103,861
Accumulated deficit (60,143) (53,849)
Total Xcel Brands, Inc. stockholders' equity 45,784 50,032
Noncontrolling interest (1,912) (1,861)
Total Stockholders' Equity 43,872 48,171
Total Liabilities and Stockholders' Equity $ 66,764 $ 71,660
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, net of allowances $ 75  
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 23,452,117 19,795,053
Common stock, shares outstanding (in shares) 23,452,117 19,795,053
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Net revenue $ 2,184,000 $ 6,050,000
Cost of goods sold   2,693,000
Gross profit 2,184,000 3,357,000
Direct operating costs and expenses    
Salaries, benefits and employment taxes 1,933,000 3,465,000
Other selling, general and administrative expenses 2,029,000 3,493,000
Total direct operating costs and expenses 3,962,000 6,958,000
Operating loss before other operating costs and expenses (1,778,000) (3,601,000)
Other operating costs and expenses (income)    
Depreciation and amortization 1,589,000 1,797,000
Asset impairment charges 2,295,000  
Loss from equity method investment 533,000 515,000
Operating loss (6,195,000) (5,913,000)
Interest and finance expense    
Interest expense 146,000  
Other interest and finance charges, net 4,000 25,000
Total interest and finance expense 150,000 25,000
Loss before income taxes (6,345,000) (5,938,000)
Income tax provision (benefit) 0 0
Net loss (6,345,000) (5,938,000)
Net loss attributable to noncontrolling interest (51,000) (295,000)
Net loss attributable to Xcel Brands, Inc. stockholders $ (6,294,000) $ (5,643,000)
Loss per common share attributable to Xcel Brands, Inc. stockholders:    
Basic net loss income per share $ (0.31) $ (0.29)
Diluted net loss income per share $ (0.31) $ (0.29)
Weighted average number of common shares outstanding:    
Basic weighted average number of shares outstanding 20,374,920 19,633,194
Diluted weighted average common shares outstanding 20,374,920 19,633,194
Net licensing revenue    
Revenues    
Net revenue $ 2,184,000 $ 2,222,000
Net sales    
Revenues    
Net revenue   $ 3,828,000
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Public Offering and Private Placement
Common Stock
Public Offering and Private Placement
Paid-in Capital
Public Offering and Private Placement
Common Stock
Consultants
Common Stock
Paid-in Capital
Consultants
Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Consultants
Total
Balances at Dec. 31, 2022         $ 20   $ 103,592 $ (32,797) $ (676)   $ 70,139
Balances (in shares) at Dec. 31, 2022         19,624,860            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Compensation expense related to stock options and restricted stock             51       51
Shares issued to consultant in connection with stock grant           $ 6       $ 6  
Shares issued to consultant in connection with stock grant (in shares)       8,334              
Net loss               (5,643) (295)   (5,938)
Balances at Mar. 31, 2023         $ 20   103,649 (38,440) (971)   $ 64,258
Balances (in shares) at Mar. 31, 2023         19,633,194            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Common stock, shares issued (in shares)                     19,795,053
Balances at Dec. 31, 2023         $ 20   103,861 (53,849) (1,861)   $ 48,171
Balances (in shares) at Dec. 31, 2023         19,795,053            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Compensation expense related to stock options and restricted stock             36       36
Shares issued in connection with stock grant           $ 98       $ 98  
Shares issued in connection with stock grant (in shares)       78,000              
Shares issued in connection with public offering and private placement transactions, net of transaction costs $ 3 $ 1,899 $ 1,902               1,902
Contra-revenue related to warrants granted to licensee             10       10
Net loss               (6,294) (51)   (6,345)
Balances at Mar. 31, 2024         $ 23   $ 105,904 $ (60,143) $ (1,912)   $ 43,872
Balances (in shares) at Mar. 31, 2024         23,452,117            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares issued in connection with public offering and private placement transactions, net of transaction costs     $ 1,900                
Common stock, shares issued (in shares)     3,579,064                
Common stock, shares issued (in shares) 3,579,064                   23,452,117
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Cash flows from operating activities    
Net loss $ (6,345) $ (5,938)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,589 1,797
Asset impairment charges 2,295  
Amortization of deferred finance costs included in interest expense 26  
Stock-based compensation and cost of licensee warrants 144 57
Undistributed proportional share of net loss of equity method investee 533 515
Changes in operating assets and liabilities:    
Accounts receivable (149) (859)
Inventory 8 (254)
Prepaid expenses and other current and non-current assets (156) 425
Deferred revenue (223) 240
Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities (560) 1,156
Lease-related assets and liabilities (237) (54)
Other long-term liabilities 466  
Net cash used in operating activities (2,609) (2,915)
Cash flows from investing activities    
Purchase of property and equipment   (81)
Net cash provided by investing activities   (81)
Cash flows from financing activities    
Proceeds from public offering and private placement transactions, net of transaction costs 1,902  
Net cash provided by (used in) financing activities 1,902  
Net decrease in cash and cash equivalents (707) (2,996)
Cash and cash equivalents at beginning of year 2,998 4,608
Cash and cash equivalents at end of year 2,291 1,612
Reconciliation to amounts on consolidated balance sheets:    
Cash and cash equivalents 1,552 1,612
Restricted cash 739  
Total cash, cash equivalents, and restricted cash 2,291 1,612
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest $ 119  
Cash paid during the period for income taxes   $ 16
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations, Background, and Basis of Presentation
3 Months Ended
Mar. 31, 2024
Nature of Operations, Background, and Basis of Presentation [Abstract]  
Nature of Operations, Background, and Basis of Presentation

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024.

The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands.

The Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its 30% ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting.
The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch by the end of May 2024.

The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.

The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.

Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. The Company had working capital (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in common stock) of approximately $2.1 million as of March 31, 2024. The Company’s unrestricted cash and cash equivalents were approximately $1.6 million as of March 31, 2024. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity.

Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Investments in Unconsolidated Affiliates and Variable Interest Entities
3 Months Ended
Mar. 31, 2024
Equity Method Investment, Summarized Financial Information [Abstract]  
Investments in Unconsolidated Affiliates and Variable Interest Entities

2.      Investments in Unconsolidated Affiliates and Variable Interest Entities  

Investment in IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

The Company accounts for its 30% interest in the ongoing operations of IM Topco as other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective percentage interests.

Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million related to its investment in IM Topco for each of the three-month periods ended March 31, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for both of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal Xcel’s share of amortization expense.

Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows:

    

For the three months ended

March 31,

($ in thousands)

2024

2023

Revenues

$

2,752

$

3,346

Gross profit

2,752

3,346

Loss from continuing operations

(437)

(143)

Net loss

(437)

(143)

Refer to Notes 10, 11, and 12 for other information regarding the Company’s ongoing relationship with IM Topco.

Investment in Orme Live, Inc.

In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s condensed consolidated balance sheets.

The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three months ended March 31, 2024 was a loss of approximately $0.02 million.

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Trademarks and Other Intangibles
3 Months Ended
Mar. 31, 2024
Trademarks and Other Intangibles [Abstract]  
Trademarks and Other Intangibles

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

March 31, 2024

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

28,950

 

39,930

Copyrights and other intellectual property

 

8 years

 

429

 

373

 

56

Total

$

69,309

$

29,323

$

39,986

    

Weighted

    

    

    

 

Average

 

December 31, 2023

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

27,431

 

41,449

Copyrights and other intellectual property

 

8 years

 

429

 

358

 

71

Total

 

  

$

69,309

$

27,789

$

41,520

Amortization expense for intangible assets was approximately $1.53 million for the three-month period ended March 31, 2024 (the "current quarter") and approximately $1.54 million for the three-month period ended March 31, 2023 (the "prior year quarter").

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Significant Contracts and Concentrations
3 Months Ended
Mar. 31, 2024
Significant Contracts [Abstract]  
Significant Contracts and Concentrations

4.      Significant Contracts and Concentrations

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.61 million and $1.52 million for the current quarter and prior year quarter, respectively, representing approximately 59% and 25% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.

As of March 31, 2024 and December 31, 2023, the Company had receivables from Qurate of $1.3 million and $1.5 million, respectively, representing approximately 37% and 43% of the Company’s total net accounts receivable, respectively.

Halston Master License

On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.2 million and $4.4 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. As of December 31, 2023, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.5 million was classified as a long-term liability. As of March 31, 2024, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.3 million was classified as a long-term liability.

The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 4.13 years. Net licensing revenue recognized from the Halston Master License was $0.6 million for the current quarter, representing approximately 30% of the Company’s total net revenue for the current quarter.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Leases

5. Leases

The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.

Lease expense (net of sublease income) included in selling, general and administrative expenses on the Company’s condensed consolidated statements of operations was approximately $0.2 million and $0.4 million for the current quarter and prior year quarter, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter.

1333 Broadway

The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property.

On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized a non-cash impairment charge of approximately $1.9 million effective February 29, 2024 (which was determined to be the date of a fundamental change to the use of the 1333 Broadway premises) related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the current quarter related to leasehold improvement assets at this location.

As of March 31, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.58 years, and the lease liability recorded on the Company’s condensed consolidated balance sheet is measured using a discount rate of 6.25%.

550 Seventh Avenue

Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year. As of March 31, 2024, no right-of-use asset or lease liability was recorded in the Company’s condensed consolidated balance sheet related to this lease, as the lease had not yet commenced.

Future Lease Obligations

As of March 31, 2024, the maturities of lease obligations were as follows:

Amount

Year

    

(in thousands)

2024 (April 1 through December 31)

$

1,164

2025

1,552

2026

 

1,552

2027

 

1,294

Total lease payments

5,562

Less: Discount

590

Present value of lease liabilities

4,972

Current portion of lease liabilities

1,278

Non-current portion of lease liabilities

$

3,694

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt

6. Debt

The Company’s net carrying amount of debt was comprised of the following:

March 31, 

December 31, 

($ in thousands)

    

2024

    

2023

Term loan debt

$

5,000

$

5,000

Unamortized deferred finance costs related to term loan debt

 

(253)

 

(279)

Total

 

4,747

 

4,721

Current portion of debt

 

1,000

 

750

Long-term debt

$

3,747

$

3,971

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.

In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

As of March 31, 2024, the aggregate remaining principal payments under the term loan were as follows:

Amount of

($ in thousands)

 

Principal

Year Ending December 31, 

    

Payment

2024 (April 1 through December 31)

$

750

2025

 

1,000

2026

1,000

2027

1,000

2028

 

1,250

Total

$

5,000

Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of March 31, 2024 and December 31, 2023.

For the current quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.15 million, reflecting an effective interest rate of approximately 11.6%.

The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio,

and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

7. Stockholders’ Equity

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense

recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized for all forms of stock-based compensation was approximately $0.13 million and $0.06 million for the current quarter and prior year quarter, respectively. For both periods, substantially all of the expense was related to directors and consultants, and was recorded as operating costs within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations.

Stock Options

A summary of the Company’s stock options activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2024

 

5,148,540

$

2.03

 

4.26

$

Granted

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(259,500)

 

4.21

 

  

 

  

Outstanding at March 31, 2024, and expected to vest

 

4,889,040

$

1.91

 

4.24

$

Exercisable at March 31, 2024

 

1,139,040

$

2.58

 

1.78

$

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.03 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2024 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.97 years.

A summary of the Company’s non-vested stock options activity for the current quarter is as follows:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2024

 

3,750,000

$

0.05

Granted

 

 

Vested

 

Forfeited or Canceled

 

 

Balance at March 31, 2024

 

3,750,000

$

0.05

Stock Awards

A summary of the Company’s restricted stock activity for the current quarter is as follows:  

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2024

 

333,333

$

3.69

Granted

 

78,000

 

1.25

Vested

 

(78,000)

 

1.25

Expired/Forfeited

 

 

Outstanding at March 31, 2024

 

333,333

$

3.69

On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which shares vested immediately.

Compensation expense related to stock awards was approximately $0.11 million for the current quarter and approximately $0.03 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2024 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 0.96 years.

Restricted Stock Units

There were no restricted stock units outstanding as of March 31, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At March 31, 2024, there were 3,025,941 shares of common stock available for future award grants under the 2021 Plan.

Shares Reserved for Issuance

As of March 31, 2024, there were 8,031,046 shares of common stock reserved for issuance, including 4,511,755 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,025,941 shares available for issuance under the 2021 Plan.

Warrants

A summary of the Company’s warrants activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2024

 

1,116,065

$

1.67

 

8.46

$

Issued

 

182,952

 

0.81

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at March 31, 2024

 

1,299,017

$

1.55

 

7.75

$

Exercisable at March 31, 2024

 

116,065

$

3.15

 

0.30

$

Warrants issued during the current quarter were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was no compensation expense recognized during the current quarter related to these warrants.

In connection with the entrance into the Halston Master License (see Note 4), the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the current quarter was approximately $0.01 million. As of March 31, 2024, no portion of this warrant had vested.

Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in the current quarter or prior year quarter.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2024
Earnings (Loss) Per Share [Abstract]  
Earnings (Loss) Per Share

8.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the three months ended March 31, 2024 and 2023:

Three Months Ended

March 31, 

    

2024

    

2023

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(6,294)

$

(5,643)

Denominator:

Basic weighted average number of shares outstanding

20,374,920

 

19,633,194

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

20,374,920

 

19,633,194

Basic net loss per share

$

(0.31)

$

(0.29)

Diluted net loss per share

$

(0.31)

$

(0.29)

As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share for such periods.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

Three Months Ended

March 31, 

    

2024

    

2023

Stock options

4,889,040

5,368,780

Warrants

1,299,017

116,065

Total

6,188,057

 

5,484,845

 

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

9.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions

10.    Related Party Transactions

IM Topco, LLC

As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

Service Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.

In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.

The Company recognized service fee income related to this agreement of $37,500 and $75,000 for the current quarter and prior year quarter, respectively.

License Agreement

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the prior year quarter, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. No amounts were paid to IM Topco during the current quarter, and as of March 31, 2024, the remaining payments due totaled $375,000.

Financing Transactions

Public Offering and Private Placement Transactions

In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 7 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and

32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

11.    Commitments and Contingencies

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).

No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Legal Matters

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment.

On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all.

As of the filing date of this Quarterly Report on Form 10-Q, there have been no definitive agreements or terms agreed to by the parties, and it is not certain when or if an agreement will be executed.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Event  
Subsequent Events

12.    Subsequent Events

IM Topco

On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 (and as subsequently amended) membership purchase agreement and the related business venture agreement. Under these amendments, the parties agreed to the following:

The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.
If IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco by October 10, 2024 under the second amendment (which totaled $375,000 as of December 31, 2023 and March 31, 2024). In April 2024, Xcel paid $100,000 of this amount to WHP.
On and after January 1, 2026, WHP shall receive 50% of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to $1.0 million.  
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables)
3 Months Ended
Mar. 31, 2024
Acquisitions, Divestitures and Variable Interest Entities[Abstract]  
Summarized financial information for IM Topco

Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows:

    

For the three months ended

March 31,

($ in thousands)

2024

2023

Revenues

$

2,752

$

3,346

Gross profit

2,752

3,346

Loss from continuing operations

(437)

(143)

Net loss

(437)

(143)

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Trademarks and Other Intangibles (Tables)
3 Months Ended
Mar. 31, 2024
Trademarks and Other Intangibles [Abstract]  
Schedule of Trademarks and Other Intangibles

    

Weighted

    

    

    

 

Average

 

March 31, 2024

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

28,950

 

39,930

Copyrights and other intellectual property

 

8 years

 

429

 

373

 

56

Total

$

69,309

$

29,323

$

39,986

    

Weighted

    

    

    

 

Average

 

December 31, 2023

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

27,431

 

41,449

Copyrights and other intellectual property

 

8 years

 

429

 

358

 

71

Total

 

  

$

69,309

$

27,789

$

41,520

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases (Tables)
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Maturities of Lease Liabilities

Amount

Year

    

(in thousands)

2024 (April 1 through December 31)

$

1,164

2025

1,552

2026

 

1,552

2027

 

1,294

Total lease payments

5,562

Less: Discount

590

Present value of lease liabilities

4,972

Current portion of lease liabilities

1,278

Non-current portion of lease liabilities

$

3,694

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt

March 31, 

December 31, 

($ in thousands)

    

2024

    

2023

Term loan debt

$

5,000

$

5,000

Unamortized deferred finance costs related to term loan debt

 

(253)

 

(279)

Total

 

4,747

 

4,721

Current portion of debt

 

1,000

 

750

Long-term debt

$

3,747

$

3,971

Schedule of Maturities of Long-Term Debt

Amount of

($ in thousands)

 

Principal

Year Ending December 31, 

    

Payment

2024 (April 1 through December 31)

$

750

2025

 

1,000

2026

1,000

2027

1,000

2028

 

1,250

Total

$

5,000

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Summary of Stock Option Activity

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2024

 

5,148,540

$

2.03

 

4.26

$

Granted

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(259,500)

 

4.21

 

  

 

  

Outstanding at March 31, 2024, and expected to vest

 

4,889,040

$

1.91

 

4.24

$

Exercisable at March 31, 2024

 

1,139,040

$

2.58

 

1.78

$

Summary of Stock Option Activity for Non-Vested Options

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2024

 

3,750,000

$

0.05

Granted

 

 

Vested

 

Forfeited or Canceled

 

 

Balance at March 31, 2024

 

3,750,000

$

0.05

Summary of Restricted Stock Activity

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2024

 

333,333

$

3.69

Granted

 

78,000

 

1.25

Vested

 

(78,000)

 

1.25

Expired/Forfeited

 

 

Outstanding at March 31, 2024

 

333,333

$

3.69

Summary of Warrant Activity

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2024

 

1,116,065

$

1.67

 

8.46

$

Issued

 

182,952

 

0.81

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding at March 31, 2024

 

1,299,017

$

1.55

 

7.75

$

Exercisable at March 31, 2024

 

116,065

$

3.15

 

0.30

$

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings (Loss) Per Share [Abstract]  
Schedule of the basic and diluted net loss per share

Three Months Ended

March 31, 

    

2024

    

2023

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(6,294)

$

(5,643)

Denominator:

Basic weighted average number of shares outstanding

20,374,920

 

19,633,194

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

20,374,920

 

19,633,194

Basic net loss per share

$

(0.31)

$

(0.29)

Diluted net loss per share

$

(0.31)

$

(0.29)

Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share

Three Months Ended

March 31, 

    

2024

    

2023

Stock options

4,889,040

5,368,780

Warrants

1,299,017

116,065

Total

6,188,057

 

5,484,845

 

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations, Background, and Basis of Presentation (Details)
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
May 31, 2022
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%    
IM Topco, LLC      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Ownership interest 30.00%   30.00%
ORME      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Ownership interest 30.00% 30.00%  
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Nature of Operations, Background, and Basis of Presentation [Abstract]          
Net Income (Loss)   $ (6,294) $ (5,643)    
Non-cash expenses   4,600      
Accumulated deficit $ (60,143) (60,143)   $ (53,849)  
Net cash used in operating activities   (2,609) (2,915)    
Working capital, Net 2,100 2,100      
Cash and cash equivalents 2,291 2,291 $ 1,612 2,998 $ 4,608
Restricted cash 739 739      
Reduction in payroll costs       6,000  
Reduction in operating expenses       9,000  
Term loan debt 5,000 5,000   $ 5,000  
Proceeds from public offering and private placement transactions, net of transaction costs $ 1,900 $ 1,902      
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) - USD ($)
3 Months Ended
May 31, 2022
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
May 27, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Loss from equity method investment   $ (533,000)   $ (515,000)  
IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership interest 30.00% 30.00%      
IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Loss from equity method investment     $ (520,000)    
Business Venture Agreement          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net cash flow distributable to members (in percent) 100.00%        
Net cash flow distributable to members $ 1,316,200        
Business Venture Agreement | WHP          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net cash flow distributable to members (in percent) 100.00%        
Net cash flow distributable to members $ 8,852,000        
IM Brand trademarks and other intellectual property rights | Disposed of by Sale | IM Topco, LLC          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Ownership interest   70.00%     70.00%
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Gross Profit $ 2,184 $ 3,357
Net (loss) income (6,345) (5,938)
IM Topco, LLC    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Revenues 2,752 3,346
Gross Profit 2,752 3,346
(Loss) income from continuing operations (437) (143)
Net (loss) income $ (437) $ (143)
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details) - ORME - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Schedule Of Asset Acquisition [Line Items]    
Members contribution $ 150  
Ownership interest 30.00% 30.00%
Proportional share of the operating results   $ 20
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) - Longaberger Licensing, LLC - Variable Interest Entity, Primary Beneficiary
3 Months Ended
Mar. 31, 2024
Schedule Of Asset Acquisition [Line Items]  
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%
Hilco Global  
Schedule Of Asset Acquisition [Line Items]  
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Trademarks and Other Intangibles - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Trademarks and Other Intangibles [Abstract]    
Amortization expense for intangible assets $ 1,530 $ 1,540
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Trademarks and Other Intangibles    
Gross Carrying Amount $ 69,309 $ 69,309
Accumulated Amortization 29,323 $ 27,789
Total $ 39,986  
Trademarks (finite-lived)    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 15 years 15 years
Gross Carrying Amount $ 68,880 $ 68,880
Accumulated Amortization 28,950 27,431
Total $ 39,930 $ 41,449
Copyrights and other intellectual property    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 8 years 8 years
Gross Carrying Amount $ 429 $ 429
Accumulated Amortization 373 358
Total $ 56 $ 71
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Significant Contracts - Qurate Agreements (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Product Information [Line Items]      
Net revenue $ 2,184 $ 6,050  
Accounts receivable 3,603   $ 3,454
Net licensing revenue      
Product Information [Line Items]      
Net revenue $ 2,184 $ 2,222  
Sales [Member] | Customer Concentration Risk [Member] | Qurate      
Product Information [Line Items]      
Concentration Risk, Percentage 59.00% 25.00%  
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue      
Product Information [Line Items]      
Net revenue $ 1,610 $ 1,520  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate      
Product Information [Line Items]      
Concentration Risk, Percentage 37.00%   43.00%
Accounts receivable $ 1,300   $ 1,500
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Significant Contracts - Halson Master License (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
May 15, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 19, 2024
Dec. 31, 2023
Subsequent Event [Line Items]          
Purchaseable stock   23,452,117     19,795,053
Deferred revenue, current   $ 889     $ 889
Deferred revenue, long-term liability   3,333     3,556
Licensing revenue   2,184 $ 6,050    
Contra-revenue related to warrants granted to licensee   $ 10      
Sales [Member] | Customer Concentration Risk [Member] | Halston License          
Subsequent Event [Line Items]          
Concentration risk, percentage   30.00%      
Warrants          
Subsequent Event [Line Items]          
Warrant term       4 years 6 months  
Purchaseable stock       182,952  
Warrants outstanding, exercise price (in dollars per share)       $ 0.8125  
Net licensing revenue          
Subsequent Event [Line Items]          
Licensing revenue   $ 2,184 $ 2,222    
Halston License          
Subsequent Event [Line Items]          
Additional royalty payable term 20 years        
Total purchase price $ 5,000        
Deferred revenue   4,200     4,400
Deferred revenue, current   900     900
Deferred revenue, long-term liability   $ 3,300     $ 3,500
Recognition period of deferred revenue   4 years 1 month 17 days      
Licensing revenue   $ 600      
Halston License | Minimum          
Subsequent Event [Line Items]          
Royalty payable term 5 years        
Halston License | Maximum          
Subsequent Event [Line Items]          
Royalty payable term 25 years        
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Feb. 29, 2024
Jan. 26, 2024
Mar. 31, 2024
Mar. 31, 2023
Lessee, Lease, Description [Line Items]        
Lease expiration date     Oct. 30, 2027  
Cash payments for operating lease expense     $ 0.4 $ 0.4
Weighted average discount rate     6.25%  
Weighted average remaining lease term for operating leases     3 years 6 months 29 days  
1333 Broadway        
Lessee, Lease, Description [Line Items]        
Annual fixed rent amount     $ 1.3  
Annual fixed sublease rent amount   $ 0.8    
1333 Broadway | Right-of-use assets        
Lessee, Lease, Description [Line Items]        
Non-cash impairment charge $ 1.9      
1333 Broadway | Leasehold improvements        
Lessee, Lease, Description [Line Items]        
Non-cash impairment charge     0.4  
530 Seventh Avenue        
Lessee, Lease, Description [Line Items]        
Annual fixed rent amount $ 0.5      
Selling, general and administrative expenses        
Lessee, Lease, Description [Line Items]        
Operating lease expense     $ 0.2 $ 0.4
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
2024 (April 1 through December 31) $ 1,164  
2025 1,552  
2026 1,552  
2027 1,294  
Total lease payments 5,562  
Less: Discount 590  
Present value of lease liabilities 4,972  
Current portion of lease liabilities 1,278 $ 1,258
Non-current portion of lease liabilities $ 3,694 $ 4,021
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Narrative (Details) - USD ($)
3 Months Ended
Oct. 19, 2023
Mar. 31, 2024
Dec. 31, 2023
Debt      
Term loan debt   $ 5,000,000 $ 5,000,000
Unamortized deferred finance costs related to term loan debt   253,000 $ 279,000
Interest expense   $ 146,000  
Effective interest rate (as percentage)   11.60%  
Swap contract with IDB      
Debt      
Derivative, fixed interest rate 9.46%    
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Swap contract with IDB | IDB      
Debt      
Derivative, basis spread on variable rate 4.25%    
New Loan Agreement      
Debt      
Term loan debt $ 5,000,000.0 $ 5,000,000  
Unamortized deferred finance costs related to term loan debt 300,000    
Quarterly installment amount $ 250,000    
New Loan Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate      
Debt      
Stated interest rate (as percentage) 4.25%    
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Net Carrying Amount of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Term loan debt $ 5,000 $ 5,000
Unamortized deferred finance costs related to term loan debt (253) (279)
Total 4,747 4,721
Current portion of debt 1,000 750
Long-term debt $ 3,747 $ 3,971
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Xcel Term Loan Remaining Principal Payments (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Oct. 19, 2023
Debt      
Total $ 5,000 $ 5,000  
New Loan Agreement      
Debt      
2024 (April 1 through December 31) 750    
2025 1,000    
2026 1,000    
2027 1,000    
2028 1,250    
Total $ 5,000   $ 5,000
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Public Offering and Private Placement Transactions (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Mar. 19, 2024
Mar. 15, 2024
Mar. 14, 2024
Mar. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Class of Stock [Line Items]            
Purchaseable stock       23,452,117 23,452,117 19,795,053
Common stock issued       23,452,117 23,452,117 19,795,053
Proceeds from public offering and private placement transactions, net of transaction costs       $ 1,900 $ 1,902  
Warrants            
Class of Stock [Line Items]            
Purchaseable stock 182,952          
Warrants outstanding, exercise price (in dollars per share) $ 0.8125          
Warrant term 4 years 6 months          
Public Offering and Private Placement            
Class of Stock [Line Items]            
Common stock issued   3,579,064        
Proceeds from public offering and private placement transactions, net of transaction costs   $ 1,900     $ 1,902  
Public Offering            
Class of Stock [Line Items]            
Purchaseable stock 3,284,422 3,284,422        
Common stock price $ 0.65 $ 0.65        
Net proceeds from the sale of shares $ 1,700          
Public Offering | Chief Executive Officer            
Class of Stock [Line Items]            
Common stock issued 146,250          
Public Offering | Director            
Class of Stock [Line Items]            
Common stock issued 146,250          
Public Offering | Executive Vice President            
Class of Stock [Line Items]            
Common stock issued 32,500          
Private Placement            
Class of Stock [Line Items]            
Common stock price     $ 0.98      
Net proceeds from the sale of private placement shares     $ 300      
Private Placement | Agreements            
Class of Stock [Line Items]            
Common stock issued     294,642      
Private Placement | Chief Executive Officer            
Class of Stock [Line Items]            
Common stock issued     132,589      
Private Placement | Director            
Class of Stock [Line Items]            
Common stock issued     132,589      
Private Placement | Executive Vice President            
Class of Stock [Line Items]            
Common stock issued     29,464      
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Equity Incentive Plans (Details)
Mar. 31, 2024
shares
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 8,031,046
2011 Equity Incentive Plan | Unexercised Stock Options  
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 4,511,755
2021 Equity Incentive Plan  
Stockholders' Equity  
Number of common stock eligible for issuance 4,000,000
Shares are granted available for issuance (in shares) 3,025,941
Shares of common stock reserved for issuance (in shares) 3,025,941
2021 Equity Incentive Plan | Unexercised Stock Options  
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 493,350
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stockholders' Equity Note [Abstract]    
Compensation expense $ 130 $ 60
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Stock Options (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Other disclosures      
Compensation expense $ 130,000 $ 60,000.00  
Employee Stock Option [Member]      
Number of Options      
Outstanding, beginning balance (in shares) 5,148,540    
Granted (in shares) 0    
Exercised (in shares) 0    
Expired/Forfeited (in shares) (259,500)    
Outstanding, ending balance (in shares) 4,889,040   5,148,540
Exercisable (in shares) 1,139,040    
Weighted Average Exercise Price      
Outstanding, beginning balance (in dollars per share) $ 2.03    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 0    
Expired/Forfeited (in dollars per share) 4.21    
Outstanding, ending balance (in dollars per share) 1.91   $ 2.03
Exercisable (in dollars per share) $ 2.58    
Other disclosures      
Outstanding Weighted Average Remaining Contractual Life (in Years) 4 years 2 months 26 days   4 years 3 months 3 days
Exercisable Weighted Average Remaining Contractual Life (in Years) 1 year 9 months 10 days    
Aggregate Intrinsic Value, Outstanding $ 0   $ 0
Aggregate Intrinsic Value, Exercisable 0    
Compensation expense 20,000.00 $ 30,000.00  
Unrecognized compensation expense $ 50,000.00    
Weighted average period of recognition 11 months 19 days    
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Non-Vested Options (Details) - Employee Stock Option [Member]
3 Months Ended
Mar. 31, 2024
$ / shares
shares
Number of Options  
Beginning Balance (in shares) | shares 3,750,000
Ending Balance (in shares) | shares 3,750,000
Weighted Average Grant Date Fair Value  
Beginning Balance (in dollars per share) | $ / shares $ 0.05
Ending Balance (in dollars per share) | $ / shares $ 0.05
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Stock Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jan. 12, 2024
Mar. 31, 2024
Mar. 31, 2023
Other disclosures      
Compensation expense   $ 130 $ 60
Consultant      
Number of Other than Options      
Granted (in shares) 78,000    
Restricted Stock      
Number of Other than Options      
Outstanding, beginning balance (in shares)   333,333  
Granted (in shares)   78,000  
Vested (in shares)   (78,000)  
Expired/Forfeited (in shares)   0  
Outstanding, ending balance (in shares)   333,333  
Weighted Average Exercise Price      
Outstanding, beginning balance (in dollars per share)   $ 3.69  
Granted (in dollars per share)   1.25  
Vested (in dollars per share)   1.25  
Expired/Forfeited (in dollars per share)   0  
Outstanding, ending balance (in dollars per share)   $ 3.69  
Other disclosures      
Unrecognized compensation expense   $ 40  
Weighted average period of recognition   11 months 15 days  
Common Stock      
Other disclosures      
Compensation expense   $ 110 $ 30
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Restricted Stock Units (Details) - shares
Mar. 31, 2024
Dec. 31, 2023
Stockholders' Equity    
Common stock, shares outstanding (in shares) 23,452,117 19,795,053
Common stock, shares issued (in shares) 23,452,117 19,795,053
Restricted Stock    
Stockholders' Equity    
Common stock, shares outstanding (in shares) 0 0
Common stock, shares issued (in shares) 0 0
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Warrants (Details) - USD ($)
3 Months Ended 12 Months Ended
May 15, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Other disclosures        
Compensation expense   $ 130,000 $ 60,000.00  
Purchaseable stock   23,452,117   19,795,053
Contra-revenue related to warrants granted to licensee   $ 10,000    
Warrants        
Number of Other than Options        
Outstanding and exercisable, beginning balance (in shares)   1,116,065    
Issued (in shares)   182,952    
Exercised (in shares)   0    
Expired/Forfeited (in shares)   0    
Outstanding, ending balance (in shares)   1,299,017   1,116,065
Exercisable (in shares)   116,065    
Weighted Average Exercise Price        
Outstanding and exercisable, beginning balance (in dollars per share)   $ 1.67    
Issued (in dollars per share)   0.81    
Exercised (in dollars per share)   0    
Expired/Forfeited (in dollars per share)   0    
Outstanding, ending balance (in dollars per share)   1.55   $ 1.67
Exercisable, ending balance (in dollars per share)   $ 3.15    
Weighted Average Remaining Contractual Life (in Years), Outstanding   7 years 9 months   8 years 5 months 15 days
Weighted Average Contractual Life (in Years), Exercisable   3 months 18 days    
Aggregate Intrinsic Value, Outstanding   $ 0   $ 0
Aggregate Intrinsic Value, Exercisable   0    
Other disclosures        
Compensation expense   $ 0 $ 0  
Warrants | Halston License        
Other disclosures        
Warrant term 10 years      
Purchaseable stock 1,000,000      
Warrants outstanding, exercise price (in dollars per share) $ 1.50      
Contra-revenue related to warrants granted to licensee $ 10,000.00      
Number of shares vested 0      
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings (Loss) Per Share [Abstract]    
Net loss attributable to Xcel Brands, Inc. stockholders $ (6,294) $ (5,643)
Basic weighted average number of shares outstanding 20,374,920 19,633,194
Diluted weighted average number of shares outstanding 20,374,920 19,633,194
Basic net loss per share $ (0.31) $ (0.29)
Diluted net loss per share $ (0.31) $ (0.29)
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 6,188,057 5,484,845
Employee Stock Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 4,889,040 5,368,780
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 1,299,017 116,065
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Effective income tax rate 0.00% 0.00%
Income tax (benefit) provision $ 0 $ 0
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions - IM Topco, LLC & License Agreement (Details) - USD ($)
1 Months Ended 3 Months Ended
Nov. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
May 31, 2022
Asset Purchase Agreement        
Payments for Royalties   $ 0    
Accrued Royalties   375,000    
IM Topco [Member] | Services Agreement        
Asset Purchase Agreement        
Due from related party       $ 300,000
Reduction in service fees $ 600,000      
Revenue from services provided   $ 37,500 $ 75,000  
IM Topco [Member] | License Agreement        
Asset Purchase Agreement        
Royalty guarantees     $ 60,000 $ 400,000
Additional royalty payments $ 450,000      
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions - Financing Transactions (Details) - USD ($)
$ / shares in Units, $ in Millions
Mar. 14, 2024
Mar. 31, 2024
Mar. 19, 2024
Mar. 15, 2024
Dec. 31, 2023
Asset Purchase Agreement          
Purchaseable stock   23,452,117     19,795,053
Common stock issued   23,452,117     19,795,053
Public Offering and Private Placement          
Asset Purchase Agreement          
Common stock issued       3,579,064  
Public Offering          
Asset Purchase Agreement          
Purchaseable stock     3,284,422 3,284,422  
Common stock price     $ 0.65 $ 0.65  
Share price     $ 0.65    
Public Offering | Chief Executive Officer          
Asset Purchase Agreement          
Common stock issued     146,250    
Public Offering | Director          
Asset Purchase Agreement          
Common stock issued     146,250    
Public Offering | Executive Vice President [Member]          
Asset Purchase Agreement          
Common stock issued     32,500    
Private Placement          
Asset Purchase Agreement          
Common stock price $ 0.98        
Net proceeds from the sale of private placement shares $ 0.3        
Private Placement | Agreements [Member]          
Asset Purchase Agreement          
Common stock issued 294,642        
Private Placement | Chief Executive Officer          
Asset Purchase Agreement          
Common stock issued 132,589        
Private Placement | Director          
Asset Purchase Agreement          
Common stock issued 132,589        
Private Placement | Executive Vice President [Member]          
Asset Purchase Agreement          
Common stock issued 29,464        
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Narrative (Details)
3 Months Ended 12 Months Ended
Feb. 16, 2024
USD ($)
May 31, 2022
USD ($)
item
Apr. 01, 2021
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Commitments and Contingencies            
Lease expiration date       Oct. 30, 2027    
Contingent obligation       $ 5,432,000 $ 5,432,000  
Additional consideration is payable to the seller $ 963,642          
Earn out payment $ 241,000          
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale            
Commitments and Contingencies            
Number of consecutive quarters for royalty payable term | item   4        
Royalty payable term   3 years        
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | Maximum            
Commitments and Contingencies            
Royalty guarantees   $ 13,300,000        
Adjustments to purchase price payable   $ 16,000,000        
Lori Goldstein Brand            
Commitments and Contingencies            
Contingent consideration     $ 12,500,000      
Contingent obligation         5,400,000  
Royalties earned       6 years    
Contingent obligation (Lori Goldstein Earn-Out)     $ 6,600,000 $ 300,000 200,000  
Additional consideration is payable to the seller       $ 700,000 $ 1,000,000.0 $ 200,000
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events (Details) - USD ($)
Apr. 12, 2024
May 31, 2022
Apr. 30, 2024
Business Venture Agreement      
Subsequent Event [Line Items]      
Net cash flow distributable to members (in percent)   100.00%  
Net cash flow distributable to members   $ 1,316,200  
WHP | Business Venture Agreement      
Subsequent Event [Line Items]      
Net cash flow distributable to members (in percent)   100.00%  
Net cash flow distributable to members   $ 8,852,000  
Subsequent Events | IM Topco, LLC      
Subsequent Event [Line Items]      
Ownership interest 30.00%    
Subsequent Events | IM Topco, LLC | If Royalties Receivable Less Than Specified Amount      
Subsequent Event [Line Items]      
Ownership interest 17.50%    
Subsequent Events | IM Topco, LLC | Twelve-month period ending March 31, 2025      
Subsequent Event [Line Items]      
Threshold royalties below which the equity interest would be transferable $ 13,500,000    
Subsequent Events | IM Topco, LLC | Year ending December 31, 2025      
Subsequent Event [Line Items]      
Threshold royalties below which the equity interest would be transferable $ 18,000,000.0    
Subsequent Events | IM Topco, LLC | WHP      
Subsequent Event [Line Items]      
Ownership interest 70.00%    
Equity interests transferred     $ 100,000
Subsequent Events | IM Topco, LLC | WHP | Business Venture Agreement      
Subsequent Event [Line Items]      
Net cash flow distributable to members (in percent) 50.00%    
Net cash flow distributable to members $ 1,000,000.0    
Subsequent Events | IM Topco, LLC | WHP | If Royalties Receivable Less Than Specified Amount      
Subsequent Event [Line Items]      
Ownership equity transferable 12.50%    
Ownership interest 82.50%    
Certain payments owed $ 375,000    
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (6,294) $ (5,643)
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 69 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 161 269 1 false 63 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation Nature of Operations, Background, and Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities Sheet http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities Investments in Unconsolidated Affiliates and Variable Interest Entities Notes 8 false false R9.htm 10301 - Disclosure - Trademarks and Other Intangibles Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles Trademarks and Other Intangibles Notes 9 false false R10.htm 10401 - Disclosure - Significant Contracts and Concentrations Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrations Significant Contracts and Concentrations Notes 10 false false R11.htm 10501 - Disclosure - Leases Sheet http://www.xcelbrands.com/role/DisclosureLeases Leases Notes 11 false false R12.htm 10601 - Disclosure - Debt Sheet http://www.xcelbrands.com/role/DisclosureDebt Debt Notes 12 false false R13.htm 10701 - Disclosure - Stockholders' Equity Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 13 false false R14.htm 10801 - Disclosure - Earnings (Loss) Per Share Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare Earnings (Loss) Per Share Notes 14 false false R15.htm 10901 - Disclosure - Income Taxes Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxes Income Taxes Notes 15 false false R16.htm 11001 - Disclosure - Related Party Transactions Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 11101 - Disclosure - Commitments and Contingencies Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 11201 - Disclosure - Subsequent Events Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEvents Subsequent Events Notes 18 false false R19.htm 30203 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables) Sheet http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesTables Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables) Tables http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities 19 false false R20.htm 30303 - Disclosure - Trademarks and Other Intangibles (Tables) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables Trademarks and Other Intangibles (Tables) Tables http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles 20 false false R21.htm 30503 - Disclosure - Leases (Tables) Sheet http://www.xcelbrands.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.xcelbrands.com/role/DisclosureLeases 21 false false R22.htm 30603 - Disclosure - Debt (Tables) Sheet http://www.xcelbrands.com/role/DisclosureDebtTables Debt (Tables) Tables http://www.xcelbrands.com/role/DisclosureDebt 22 false false R23.htm 30703 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.xcelbrands.com/role/DisclosureStockholdersEquity 23 false false R24.htm 30803 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare 24 false false R25.htm 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails Nature of Operations, Background, and Basis of Presentation (Details) Details http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation 25 false false R26.htm 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) Details 26 false false R27.htm 40201 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) Sheet http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) Details 27 false false R28.htm 40202 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details) Sheet http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details) Details 28 false false R29.htm 40203 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details) Sheet http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details) Details 29 false false R30.htm 40205 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) Sheet http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) Details 30 false false R31.htm 40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails Trademarks and Other Intangibles - Narrative (Details) Details 31 false false R32.htm 40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Details 32 false false R33.htm 40402 - Disclosure - Significant Contracts - Qurate Agreements (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails Significant Contracts - Qurate Agreements (Details) Details 33 false false R34.htm 40403 - Disclosure - Significant Contracts - Halson Master License (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails Significant Contracts - Halson Master License (Details) Details 34 false false R35.htm 40501 - Disclosure - Leases - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails Leases - Narrative (Details) Details 35 false false R36.htm 40502 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 36 false false R37.htm 40601 - Disclosure - Debt - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails Debt - Narrative (Details) Details 37 false false R38.htm 40602 - Disclosure - Debt - Net Carrying Amount of Debt (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails Debt - Net Carrying Amount of Debt (Details) Details 38 false false R39.htm 40603 - Disclosure - Debt - Xcel Term Loan Remaining Principal Payments (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails Debt - Xcel Term Loan Remaining Principal Payments (Details) Details 39 false false R40.htm 40701 - Disclosure - Stockholders' Equity - Public Offering and Private Placement Transactions (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails Stockholders' Equity - Public Offering and Private Placement Transactions (Details) Details 40 false false R41.htm 40702 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails Stockholders' Equity - Equity Incentive Plans (Details) Details 41 false false R42.htm 40703 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails Stockholders' Equity - Stock-based Compensation (Details) Details 42 false false R43.htm 40704 - Disclosure - Stockholders' Equity - Stock Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails Stockholders' Equity - Stock Options (Details) Details 43 false false R44.htm 40705 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails Stockholders' Equity - Non-Vested Options (Details) Details 44 false false R45.htm 40706 - Disclosure - Stockholders' Equity - Stock Awards (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails Stockholders' Equity - Stock Awards (Details) Details 45 false false R46.htm 40707 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails Stockholders' Equity - Restricted Stock Units (Details) Details 46 false false R47.htm 40708 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 47 false false R48.htm 40801 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 48 false false R49.htm 40802 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 49 false false R50.htm 40901 - Disclosure - Income Taxes (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.xcelbrands.com/role/DisclosureIncomeTaxes 50 false false R51.htm 41001 - Disclosure - Related Party Transactions - IM Topco, LLC & License Agreement (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails Related Party Transactions - IM Topco, LLC & License Agreement (Details) Details 51 false false R52.htm 41002 - Disclosure - Related Party Transactions - Financing Transactions (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails Related Party Transactions - Financing Transactions (Details) Details 52 false false R53.htm 41101 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 53 false false R54.htm 41202 - Disclosure - Subsequent Events (Details) Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.xcelbrands.com/role/DisclosureSubsequentEvents 54 false false R55.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Uncategorized 55 false false R56.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Cover 56 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 12 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesIssued, us-gaap:WarrantsAndRightsOutstandingTerm, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, xelb:AssetAcquisitionRoyaltiesTerm, xelb:DeferredRevenueRecognitionPeriod, xelb:RoyaltyPayableTerm - xelb-20240331x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - xelb-20240331x10q.htm 9 [dq-0712-Presentation-Base-Set-Order] Role '41202 - Disclosure - Subsequent Events (Details)', a level 4, Detail role, appears before '995410 - Disclosure - Pay vs Performance Disclosure', a level 1, Note role. https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd 30, xelb-20240331.xsd 225 xelb-20240331.xsd xelb-20240331_cal.xml xelb-20240331_def.xml xelb-20240331_lab.xml xelb-20240331_pre.xml xelb-20240331x10q.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 75 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "xelb-20240331x10q.htm": { "nsprefix": "xelb", "nsuri": "http://www.xcelbrands.com/20240331", "dts": { "schema": { "local": [ "xelb-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] }, "calculationLink": { "local": [ "xelb-20240331_cal.xml" ] }, "definitionLink": { "local": [ "xelb-20240331_def.xml" ] }, "labelLink": { "local": [ "xelb-20240331_lab.xml" ] }, "presentationLink": { "local": [ "xelb-20240331_pre.xml" ] }, "inline": { "local": [ "xelb-20240331x10q.htm" ] } }, "keyStandard": 230, "keyCustom": 39, "axisStandard": 31, "axisCustom": 0, "memberStandard": 27, "memberCustom": 30, "hidden": { "total": 21, "http://fasb.org/us-gaap/2023": 13, "http://www.xcelbrands.com/20240331": 3, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 161, "entityCount": 1, "segmentCount": 63, "elementCount": 548, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 470, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "longName": "00100 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023__O1Eh6-gz0eTdL5CwdPdpw", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R3": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical", "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "longName": "00200 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_3_31_2023_JAOGP50oQEi4vrHOtuSFkA", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R5": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity", "longName": "00300 - Statement - Consolidated Statements of Stockholders' Equity", "shortName": "Consolidated Statements of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_kBEaKrOKjUq0VURirYGmjw", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_kBEaKrOKjUq0VURirYGmjw", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AmortizationOfFinancingCosts", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R7": { "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation", "longName": "10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation", "shortName": "Nature of Operations, Background, and Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities", "longName": "10201 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities", "shortName": "Investments in Unconsolidated Affiliates and Variable Interest Entities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles", "longName": "10301 - Disclosure - Trademarks and Other Intangibles", "shortName": "Trademarks and Other Intangibles", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrations", "longName": "10401 - Disclosure - Significant Contracts and Concentrations", "shortName": "Significant Contracts and Concentrations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.xcelbrands.com/role/DisclosureLeases", "longName": "10501 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.xcelbrands.com/role/DisclosureDebt", "longName": "10601 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquity", "longName": "10701 - Disclosure - Stockholders' Equity", "shortName": "Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare", "longName": "10801 - Disclosure - Earnings (Loss) Per Share", "shortName": "Earnings (Loss) Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxes", "longName": "10901 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions", "longName": "11001 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies", "longName": "11101 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEvents", "longName": "11201 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesTables", "longName": "30203 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables)", "shortName": "Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables", "longName": "30303 - Disclosure - Trademarks and Other Intangibles (Tables)", "shortName": "Trademarks and Other Intangibles (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.xcelbrands.com/role/DisclosureLeasesTables", "longName": "30503 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.xcelbrands.com/role/DisclosureDebtTables", "longName": "30603 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables", "longName": "30703 - Disclosure - Stockholders' Equity (Tables)", "shortName": "Stockholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables", "longName": "30803 - Disclosure - Earnings (Loss) Per Share (Tables)", "shortName": "Earnings (Loss) Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "longName": "40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details)", "shortName": "Nature of Operations, Background, and Basis of Presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_RLvk8BN_LkKMKLSTy6T6Fg", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": null }, "R26": { "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "longName": "40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details)", "shortName": "Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:OtherNoncashExpense", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R27": { "role": "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "longName": "40201 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details)", "shortName": "Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_xelb_IMTopcoLLCMember_-lCHzEV7dE-bMq2qVr96IQ", "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R28": { "role": "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "longName": "40202 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details)", "shortName": "Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:GrossProfit", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_srt_OwnershipAxis_xelb_IMTopcoLLCMember_pEB2GrNOw02rg8UFzhja7A", "name": "us-gaap:Revenues", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R29": { "role": "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "longName": "40203 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details)", "shortName": "Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "Duration_12_1_2023_To_12_31_2023_srt_OwnershipAxis_xelb_OrmeLiveMember_tVhrCGZhy0GZaZEr3eputg", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_12_1_2023_To_12_31_2023_srt_OwnershipAxis_xelb_OrmeLiveMember_tVhrCGZhy0GZaZEr3eputg", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "longName": "40205 - Disclosure - Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details)", "shortName": "Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_RLvk8BN_LkKMKLSTy6T6Fg", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_dei_LegalEntityAxis_xelb_HilcoGlobalMember_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_LgeFqP7ZU0-whXHgivWOAQ", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R31": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "longName": "40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details)", "shortName": "Trademarks and Other Intangibles - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails", "longName": "40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "shortName": "Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "longName": "40402 - Disclosure - Significant Contracts - Qurate Agreements (Details)", "shortName": "Significant Contracts - Qurate Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_srt_MajorCustomersAxis_xelb_QurateRetailGroupMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_kFk0nHqQ2UigxiY46AaagQ", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R34": { "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "longName": "40403 - Disclosure - Significant Contracts - Halson Master License (Details)", "shortName": "Significant Contracts - Halson Master License (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "As_Of_12_31_2023__O1Eh6-gz0eTdL5CwdPdpw", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_srt_MajorCustomersAxis_xelb_HalstonBrandMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_Vd_dmSKOs0qmj-aHvKqVUg", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R35": { "role": "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "longName": "40501 - Disclosure - Leases - Narrative (Details)", "shortName": "Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LeaseExpirationDate1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:OperatingLeasePayments", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "us-gaap:OperatingLeasePayments", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R36": { "role": "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "longName": "40502 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "longName": "40601 - Disclosure - Debt - Narrative (Details)", "shortName": "Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R38": { "role": "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "longName": "40602 - Disclosure - Debt - Net Carrying Amount of Debt (Details)", "shortName": "Debt - Net Carrying Amount of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R39": { "role": "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails", "longName": "40603 - Disclosure - Debt - Xcel Term Loan Remaining Principal Payments (Details)", "shortName": "Debt - Xcel Term Loan Remaining Principal Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_us-gaap_DebtInstrumentAxis_xelb_NewLoanAndSecurityAgreementMember_ygk3Tjd09UqPV0QbVYaw4Q", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R40": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "longName": "40701 - Disclosure - Stockholders' Equity - Public Offering and Private Placement Transactions (Details)", "shortName": "Stockholders' Equity - Public Offering and Private Placement Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "As_Of_12_31_2023__O1Eh6-gz0eTdL5CwdPdpw", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_3_19_2024_To_3_19_2024_us-gaap_SubsidiarySaleOfStockAxis_xelb_PublicOfferingMember_5GRxldfOyUaGBx03sk8JQA", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R41": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "longName": "40702 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details)", "shortName": "Stockholders' Equity - Equity Incentive Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_K-18c3g-80GNNkfyepfDtw", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "longName": "40703 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details)", "shortName": "Stockholders' Equity - Stock-based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": null }, "R43": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "longName": "40704 - Disclosure - Stockholders' Equity - Stock Options (Details)", "shortName": "Stockholders' Equity - Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_tDyYuCqaB0WVgLTdz7moFg", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R44": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "longName": "40705 - Disclosure - Stockholders' Equity - Non-Vested Options (Details)", "shortName": "Stockholders' Equity - Non-Vested Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_us-gaap_EmployeeStockOptionMember_ppw1_p4ksk27GQuUVIHQhQ", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_us-gaap_EmployeeStockOptionMember_ppw1_p4ksk27GQuUVIHQhQ", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "longName": "40706 - Disclosure - Stockholders' Equity - Stock Awards (Details)", "shortName": "Stockholders' Equity - Stock Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_12_2024_To_1_12_2024_srt_TitleOfIndividualAxis_xelb_ConsultantMember_4zMveWxxcUWJGFY16JASwA", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R46": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "longName": "40707 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details)", "shortName": "Stockholders' Equity - Restricted Stock Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_12_31_2023__O1Eh6-gz0eTdL5CwdPdpw", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2024_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_sM4o9ZtQ9E-cU8N9k13AzQ", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R47": { "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "longName": "40708 - Disclosure - Stockholders' Equity - Warrants (Details)", "shortName": "Stockholders' Equity - Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_us-gaap_AwardTypeAxis_us-gaap_WarrantMember_Q3WS3GzyvU2EpBD1EgC8mg", "name": "xelb:ClassOfWarrantOrRightGranted", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R48": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "longName": "40801 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "shortName": "Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "longName": "40802 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "shortName": "Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails", "longName": "40901 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails", "longName": "41001 - Disclosure - Related Party Transactions - IM Topco, LLC & License Agreement (Details)", "shortName": "Related Party Transactions - IM Topco, LLC & License Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:PaymentsForRoyalties", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:PaymentsForRoyalties", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "longName": "41002 - Disclosure - Related Party Transactions - Financing Transactions (Details)", "shortName": "Related Party Transactions - Financing Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_12_31_2023__O1Eh6-gz0eTdL5CwdPdpw", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_DOO7PIVX90uY4JNZL70Pew", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_19_2024_us-gaap_SubsidiarySaleOfStockAxis_xelb_PublicOfferingMember_-DM7VjPYC0mJP2hpwNT4LA", "name": "us-gaap:SharesIssuedPricePerShare", "unitRef": "Unit_Divide_USD_shares_B2nG77wan02Pibpf0NBFew", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R53": { "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "longName": "41101 - Disclosure - Commitments and Contingencies - Narrative (Details)", "shortName": "Commitments and Contingencies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:LeaseExpirationDate1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_16_2024_To_2_16_2024_OByJ9E3AuUa4wSJr6_GcyQ", "name": "xelb:AssetAcquisitionAdditionalConsiderationPayableToSeller", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R54": { "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails", "longName": "41202 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "Duration_5_31_2022_To_5_31_2022_us-gaap_TypeOfArrangementAxis_xelb_BusinessVentureAgreementMember_JT-co4iS1kC2Yalyq82R_Q", "name": "xelb:PercentageOfNetCashFlowDistributableToMembers", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_4_12_2024_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_xelb_IMTopcoLLCMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_WkQMyAOYUE6S-Eyg2l_Avg", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "Unit_Standard_pure_JBwbMEMsYUakxVjFCegJ6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "unique": true } }, "R55": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Uncategorized", "order": "55", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_rYExqWnxxkmhXUVKARmZzQ", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true }, "uniqueAnchor": null }, "R56": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Cover", "order": "56", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_3_31_2024_NUYDj9HCa0umTmvdXj_rwA", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "xelb-20240331x10q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable, accrued expenses and other current liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r20" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r663" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable", "verboseLabel": "Accounts receivable, net of allowances for credit losses of $75 at March 31, 2024 and December 31, 2023", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r239", "r240" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes, Current", "terseLabel": "Accrued income taxes payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r93", "r138" ] }, "us-gaap_AccruedRoyaltiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedRoyaltiesCurrent", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Royalties, Current", "terseLabel": "Accrued Royalties", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r22", "r672" ] }, "xelb_AcquisitionsAndDivestituresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AcquisitionsAndDivestituresAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Acquisitions, Divestitures and Variable Interest Entities[Abstract]" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r747" ] }, "us-gaap_AdditionalCashFlowElementsSummationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalCashFlowElementsSummationsAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Additional Cash Flow Elements, Summations [Abstract]", "terseLabel": "Reconciliation to amounts on consolidated balance sheets:" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r97", "r696", "r885" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Paid-In Capital [Member]", "verboseLabel": "Paid-in Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r397", "r398", "r399", "r594", "r813", "r814", "r815", "r866", "r886" ] }, "xelb_AdditionalRoyaltyPayableTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AdditionalRoyaltyPayableTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Additional amount of time that that royalties will be payable.", "label": "Additional Royalty Payable Term", "terseLabel": "Additional royalty payable term" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r753" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r753" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r753" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r753" ] }, "xelb_AdjustmentToPurchasePricePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AdjustmentToPurchasePricePayable", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount payable as adjustment to purchase price previously received by the company.", "label": "Adjustment to Purchase Price Payable", "terseLabel": "Adjustments to purchase price payable" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Compensation expense related to stock options and restricted stock", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r62", "r63", "r367" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r718", "r729", "r739", "r764" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r721", "r732", "r742", "r767" ] }, "xelb_AgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AgreementsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents agreements.", "label": "Agreements [Member]", "terseLabel": "Agreements" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r753" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r760" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r725", "r733", "r743", "r760", "r768", "r772", "r780" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r778" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Allocated Share-based Compensation Expense", "terseLabel": "Compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r395", "r400" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowances", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r168", "r241", "r292" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Issuance Costs", "verboseLabel": "Amortization of deferred finance costs included in interest expense", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r105", "r338", "r471", "r808" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization expense for intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r5", "r44", "r48" ] }, "xelb_AnnualFixedRentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AnnualFixedRentAmount", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of annual fixed rent over the term of the lease.", "label": "Annual Fixed Rent Amount", "terseLabel": "Annual fixed rent amount" } } }, "auth_ref": [] }, "xelb_AnnualFixedSubleaseRentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AnnualFixedSubleaseRentAmount", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of annual fixed sublease rent over the term of the lease.", "label": "Annual Fixed Sublease Rent Amount", "terseLabel": "Annual fixed sublease rent amount" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Dilutive securities", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r215" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r419" ] }, "xelb_AssetAcquisitionAdditionalConsiderationPayableToSeller": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionAdditionalConsiderationPayableToSeller", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additional consideration payable to seller.", "label": "Asset Acquisition, Additional Consideration Payable To Seller", "terseLabel": "Additional consideration is payable to the seller" } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Axis]", "documentation": "Information by asset acquisition." } } }, "auth_ref": [ "r864" ] }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Current", "verboseLabel": "Current portion of contingent obligation", "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current." } } }, "auth_ref": [ "r864" ] }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Long-term portion of contingent obligations", "verboseLabel": "Contingent obligation", "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent." } } }, "auth_ref": [ "r864" ] }, "xelb_AssetAcquisitionContingentObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionContingentObligation", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Contingent Obligation", "label": "Asset Acquisition, Contingent Obligation", "verboseLabel": "Contingent obligation (Lori Goldstein Earn-Out)" } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Domain]", "documentation": "Asset acquisition." } } }, "auth_ref": [ "r864" ] }, "xelb_AssetAcquisitionEarnOutPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionEarnOutPayments", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of earn out payments made by the Company.", "label": "Asset Acquisition, Earn Out Payments", "terseLabel": "Earn out payment" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionPrice", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of purchase price of asset acquired.", "label": "Asset Acquisition Price", "terseLabel": "Total purchase price" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionRoyaltiesTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionRoyaltiesTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Royalties Term", "label": "Asset Acquisition, Royalties Term", "terseLabel": "Royalties earned" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionsAbstract", "lang": { "en-us": { "role": { "documentation": "Asset Acquisitions [Abstract]", "label": "Asset Acquisitions [Abstract]" } } }, "auth_ref": [] }, "xelb_AssetAcquisitionsContingentConsiderationAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "AssetAcquisitionsContingentConsiderationAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum aggregate amount of contingent considerations.", "label": "Asset Acquisitions, Contingent Consideration, Amount", "terseLabel": "Contingent consideration" } } }, "auth_ref": [] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Asset impairment charges", "terseLabel": "Asset impairment charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r5", "r49" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r136", "r161", "r185", "r221", "r230", "r234", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r421", "r425", "r457", "r542", "r619", "r696", "r709", "r830", "r831", "r872" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r156", "r170", "r185", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r421", "r425", "r457", "r696", "r830", "r831", "r872" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current Assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets", "totalLabel": "Total non-current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r185", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r421", "r425", "r457", "r830", "r831", "r872" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current Assets:" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r775" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r776" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r771" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r771" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r771" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r771" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r771" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r771" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r774" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r773" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r772" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r772" ] }, "xelb_BusinessVentureAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "BusinessVentureAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Business Venture Agreement.", "label": "Business Venture Agreement [Member]", "terseLabel": "Business Venture Agreement" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r33", "r158", "r670" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Total cash, cash equivalents, and restricted cash", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r33", "r112", "r183" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r112" ] }, "xelb_CertainPaymentsOwed": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "CertainPaymentsOwed", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of certain payments owed per agreements made.", "label": "Certain Payments Owed", "terseLabel": "Certain payments owed" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r751" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer" } } }, "auth_ref": [ "r818" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r164", "r165", "r166", "r220", "r344", "r345", "r346", "r348", "r351", "r356", "r358", "r583", "r584", "r585", "r586", "r686", "r786", "r809" ] }, "xelb_ClassOfWarrantOrRightExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExercisable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercisable.", "label": "Class Of Warrant or Right, Exercisable", "terseLabel": "Exercisable (in shares)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisableInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExercisableInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average grant date fair value of warrants exercisable.", "label": "Class of Warrant or Right Exercisable In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercisable, ending balance (in dollars per share)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExercisableInPeriodWeightedAverageRemainingContractualTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of the exercisable warrants.", "label": "Class of Warrant or Right, Exercisable In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (in Years), Exercisable" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisableIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExercisableIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The exercisable intrinsic value of the warrants.", "label": "Class of Warrant or Right, Exercisable Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrants outstanding, exercise price (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r359" ] }, "xelb_ClassOfWarrantOrRightExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExercised", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were exercised during the reporting period.", "label": "Class Of Warrant Or Right, Exercised", "terseLabel": "Exercised (in shares)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Exercised In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Exercised In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercised (in dollars per share)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightExpiredForfeitedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightExpiredForfeitedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired, forfeited in period weighted average grant date fair value.", "label": "Class Of Warrant Or Right Expired, Forfeited In Period Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightForfeited", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were forfeited during the reporting period.", "label": "Class Of Warrant Or Right, Forfeited", "terseLabel": "Expired/Forfeited (in shares)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightGranted": { "xbrltype": "sharesItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightGranted", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were granted during the reporting period.", "label": "Class Of Warrant Or Right, Granted", "terseLabel": "Issued (in shares)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Issued (in dollars per share)" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in shares)", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in dollars per share)" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life (in Years), Outstanding" } } }, "auth_ref": [] }, "xelb_ClassOfWarrantOrRightOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ClassOfWarrantOrRightOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding Intrinsic Value", "label": "Class Of Warrant Or Right, Outstanding Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r752" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r752" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingency", "verboseLabel": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r27", "r77", "r543", "r605" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r121", "r308", "r309", "r664", "r826" ] }, "xelb_CommitmentsAndContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "CommitmentsAndContingenciesLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Commitments and Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies" } } }, "auth_ref": [] }, "xelb_CommitmentsAndContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "CommitmentsAndContingenciesTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from commitments and contingencies.", "label": "Commitments and Contingencies [Table]", "terseLabel": "Commitments and Contingencies [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Capital Shares Reserved for Future Issuance", "verboseLabel": "Shares of common stock reserved for issuance (in shares)", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r28" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock", "terseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r699", "r700", "r701", "r703", "r704", "r705", "r706", "r813", "r814", "r866", "r883", "r886" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r96" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r96", "r606" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued", "verboseLabel": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r96" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Purchaseable stock", "verboseLabel": "Common stock, shares outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r96", "r606", "r625", "r886", "r887" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.001 par value, 50,000,000 shares authorized, and 23,452,117 and 19,795,053 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r96", "r546", "r696" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r757" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r756" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r758" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r755" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r38", "r40", "r71", "r72", "r238", "r663" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r38", "r40", "r71", "r72", "r238", "r578", "r663" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r38", "r40", "r71", "r72", "r238", "r663", "r790" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrations" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Significant Contracts and Concentrations", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r115" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r38", "r40", "r71", "r72", "r238" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r37", "r38", "r40", "r41", "r71", "r134", "r663" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r38", "r40", "r71", "r72", "r238", "r663" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r189", "r421", "r422", "r425", "r426", "r497", "r665", "r829", "r832", "r833" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r189", "r421", "r422", "r425", "r426", "r497", "r665", "r829", "r832", "r833" ] }, "xelb_ConsultantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ConsultantMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Consultant" } } }, "auth_ref": [] }, "xelb_ConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ConsultantsMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to consultants.", "label": "Consultants" } } }, "auth_ref": [] }, "xelb_ContraRevenueFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ContraRevenueFromWarrantExercises", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "The amount of the reduction of revenue from warrants associated with the respective agreement.", "label": "Contra Revenue from Warrant Exercises", "terseLabel": "Contra-revenue related to warrants granted to licensee" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r108", "r532" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "xelb_OperatingIncomeLossBeforeOtherExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Total direct operating costs and expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r106" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "verboseLabel": "Direct operating costs and expenses" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r187", "r188", "r326", "r346", "r495", "r673", "r675" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document And Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r39", "r238" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r18", "r92", "r93", "r137", "r139", "r189", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r472", "r681", "r682", "r683", "r684", "r685", "r810" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "terseLabel": "Term loan debt", "totalLabel": "Total", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r18", "r139", "r340" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Effective interest rate (as percentage)", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r24", "r74", "r335" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Stated interest rate (as percentage)", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r24", "r324" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r189", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r472", "r681", "r682", "r683", "r684", "r685", "r810" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r25", "r189", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r472", "r681", "r682", "r683", "r684", "r685", "r810" ] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment, Principal", "terseLabel": "Quarterly installment amount", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r25" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r25", "r53", "r56", "r73", "r74", "r76", "r78", "r124", "r125", "r189", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r472", "r681", "r682", "r683", "r684", "r685", "r810" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]", "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan." } } }, "auth_ref": [ "r60" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "negatedLabel": "Unamortized deferred finance costs related to term loan debt", "verboseLabel": "Unamortized deferred finance costs related to term loan debt", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r75", "r835" ] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r803" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue, current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r802" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue", "verboseLabel": "Deferred revenue, long-term liability", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r803" ] }, "xelb_DeferredRevenueRecognitionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "DeferredRevenueRecognitionPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "Period of time that the deferred revenue will be recognized over.", "label": "Deferred Revenue, Recognition Period", "terseLabel": "Recognition period of deferred revenue" } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense", "verboseLabel": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r5", "r224" ] }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeBasisSpreadOnVariableRate", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Basis Spread on Variable Rate", "terseLabel": "Derivative, basis spread on variable rate", "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Fixed Interest Rate", "terseLabel": "Derivative, fixed interest rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "DirectorMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Director" } } }, "auth_ref": [ "r818", "r884" ] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r154" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Disposed of by Sale", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r6", "r15" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r689", "r690" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r713" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r746" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings (Loss) Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Basic net loss income per share", "verboseLabel": "Basic net loss per share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r177", "r198", "r199", "r200", "r201", "r202", "r208", "r210", "r212", "r213", "r214", "r218", "r449", "r450", "r539", "r557", "r676" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Loss per common share attributable to Xcel Brands, Inc. stockholders:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net loss income per share", "verboseLabel": "Diluted net loss per share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r177", "r198", "r199", "r200", "r201", "r202", "r210", "r212", "r213", "r214", "r218", "r449", "r450", "r539", "r557", "r676" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Weighted average number of common shares outstanding:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings (Loss) Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r207", "r215", "r216", "r217" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "verboseLabel": "Effective income tax rate", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r403" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation expense", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r396" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period of recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r396" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r711" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r711" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r711" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r785" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r711" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r711" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r711" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r711" ] }, "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]", "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan." } } }, "auth_ref": [ "r60" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r151", "r173", "r174", "r175", "r190", "r191", "r192", "r195", "r203", "r205", "r219", "r285", "r291", "r360", "r397", "r398", "r399", "r409", "r410", "r430", "r432", "r433", "r434", "r435", "r437", "r448", "r462", "r463", "r464", "r465", "r466", "r467", "r490", "r568", "r569", "r570", "r594", "r647" ] }, "xelb_EquityIncentivePlan2011Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "EquityIncentivePlan2011Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2011 Equity Incentive Plan.", "label": "2011 Equity Incentive Plan" } } }, "auth_ref": [] }, "xelb_EquityIncentivePlan2021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "EquityIncentivePlan2021Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2021 Equity Incentive Plan.", "label": "2021 Equity Incentive Plan" } } }, "auth_ref": [] }, "xelb_EquityInterestsTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "EquityInterestsTransferred", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of equity interests transferred from the Company to another.", "label": "Equity Interests Transferred", "terseLabel": "Equity interests transferred" } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r276", "r277", "r279" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership interest", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r276" ] }, "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentSummarizedFinancialInformationAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investment, Summarized Financial Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments", "terseLabel": "Equity method investment in IM Topco, LLC", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r227", "r274", "r801", "r823" ] }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntities" ], "lang": { "en-us": { "role": { "label": "Equity Method Investment", "terseLabel": "Investments in Unconsolidated Affiliates and Variable Interest Entities", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group." } } }, "auth_ref": [ "r148", "r278", "r281", "r787" ] }, "us-gaap_EquityMethodInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesTables" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Summarized financial information for IM Topco", "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information." } } }, "auth_ref": [ "r275" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r754" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r718", "r729", "r739", "r764" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r715", "r726", "r736", "r761" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r760" ] }, "srt_ExecutiveVicePresidentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExecutiveVicePresidentMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Executive Vice President [Member]", "terseLabel": "Executive Vice President" } } }, "auth_ref": [ "r818" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Asset Purchase Agreement", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r452", "r453", "r454" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r452", "r453", "r454" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r339", "r356", "r438", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r556", "r680", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r819", "r820", "r821", "r822" ] }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Trademarks and Other Intangibles" } } }, "auth_ref": [] }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of finite-lived and indefinite-lived intangible assets, excluding goodwill, in total and by major class.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Useful Life", "presentationGuidance": "Weighted Average Amortization Period", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "verboseLabel": "Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r159", "r303" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r301", "r302", "r303", "r304", "r533", "r537" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r118", "r537" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r45", "r47" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r118", "r533" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r722", "r733", "r743", "r768" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r722", "r733", "r743", "r768" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r722", "r733", "r743", "r768" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r722", "r733", "r743", "r768" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r722", "r733", "r743", "r768" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Trademarks and Other Intangibles [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "Trademarks and Other Intangibles", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r117" ] }, "us-gaap_GranteeStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusAxis", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Grantee Status [Axis]", "documentation": "Information by status of recipient to whom award is granted." } } }, "auth_ref": [ "r366", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394" ] }, "us-gaap_GranteeStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GranteeStatusDomain", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Grantee Status [Domain]", "documentation": "Status of recipient to whom award is granted." } } }, "auth_ref": [ "r366", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "xelb_OperatingIncomeLossBeforeOtherExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r107", "r185", "r221", "r229", "r233", "r235", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r457", "r678", "r830" ] }, "xelb_HalstonBrandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "HalstonBrandMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the Halston Brand (the \"Halston License\").", "label": "Halston Brand [Member]", "terseLabel": "Halston License" } } }, "auth_ref": [] }, "xelb_HilcoGlobalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "HilcoGlobalMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails" ], "lang": { "en-us": { "role": { "documentation": "Hilco Global [Member]", "label": "Hilco Global" } } }, "auth_ref": [] }, "xelb_IMTopcoLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "IMTopcoLLCMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to IM Topco, LLC.", "label": "IM Topco, LLC" } } }, "auth_ref": [] }, "xelb_IfRoyaltiesReceivableLessThanSpecifiedAmountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "IfRoyaltiesReceivableLessThanSpecifiedAmountMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to the event where royalties receivable less that specified amount.", "label": "If Royalties Receivable Less Than Specified Amount" } } }, "auth_ref": [] }, "xelb_ImTopcoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ImTopcoMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM Topco.", "label": "IM Topco [Member]" } } }, "auth_ref": [] }, "xelb_ImWhpLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ImWhpLlcMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM WHP LLC.", "label": "WHP" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfLeasehold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLeasehold", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Leasehold", "terseLabel": "Non-cash impairment charge", "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced." } } }, "auth_ref": [ "r5", "r49" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r102", "r143", "r221", "r229", "r233", "r235", "r540", "r552", "r678" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "(Loss) income from continuing operations", "verboseLabel": "Proportional share of the operating results", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r130", "r185", "r194", "r221", "r229", "r233", "r235", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r450", "r457", "r552", "r678", "r830" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Undistributed proportional share of net loss of equity method investee", "verboseLabel": "Loss from equity method investment", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r5", "r103", "r142", "r225", "r274", "r551" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r689", "r690" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r10", "r15", "r19", "r80", "r81", "r82", "r83", "r84", "r85", "r86", "r87", "r88", "r120" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r305", "r307", "r632" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r307", "r632" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r186", "r401", "r404", "r405", "r406", "r411", "r413", "r414", "r415", "r588" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax (benefit) provision", "verboseLabel": "Income tax provision (benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r146", "r147", "r204", "r205", "r226", "r402", "r412", "r558" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid", "terseLabel": "Cash paid during the period for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r32", "r34" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r668" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Lease-related assets and liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r792", "r807" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Liabilities", "verboseLabel": "Other long-term liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpensesOther", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other current and non-current assets", "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r725", "r733", "r743", "r760", "r768", "r772", "r780" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r778" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r714", "r784" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r714", "r784" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r714", "r784" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Trademarks and other intangibles, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r43", "r46" ] }, "us-gaap_IntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntellectualPropertyMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Copyrights and other intellectual property", "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights." } } }, "auth_ref": [ "r17" ] }, "us-gaap_InterestAndDebtExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpenseAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest and Debt Expense [Abstract]", "verboseLabel": "Interest and finance expense" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "terseLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r110", "r336", "r342", "r684", "r685" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Net", "negatedTotalLabel": "Total interest and finance expense", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r145" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid during the period for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r178", "r181", "r182" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "verboseLabel": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r169", "r671", "r696" ] }, "xelb_IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Isaac Mizrahi Brand trademarks and other intellectual property.", "label": "IM Intellectual Property", "terseLabel": "IM Brand trademarks and other intellectual property rights" } } }, "auth_ref": [] }, "xelb_IsaacMizrahiSaleTransactionWithImTopcoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "IsaacMizrahiSaleTransactionWithImTopcoMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Isaac Mizrahi sale transaction with IM Topco.", "label": "Isaac Mizrahi Sale Transaction with IM Topco [Member]", "terseLabel": "Isaac Mizrahi sale transaction with IM Topco" } } }, "auth_ref": [] }, "xelb_IsraelDiscountBankOfNewYorkMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "IsraelDiscountBankOfNewYorkMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the IDB (Israel Discount Bank of New York).", "label": "Israel Discount Bank of New York [Member]", "terseLabel": "IDB" } } }, "auth_ref": [] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Salaries Benefits And Employment Taxes", "verboseLabel": "Salaries, benefits and employment taxes", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r806" ] }, "xelb_Lease1113BroadwayMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "Lease1113BroadwayMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents the lease for 1113 Broadway.", "label": "Lease 1113 Broadway [Member]", "terseLabel": "1333 Broadway" } } }, "auth_ref": [] }, "xelb_Lease530SeventhAvenueMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "Lease530SeventhAvenueMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents the lease for 530 Seventh Avenue.", "label": "Lease 530 Seventh Avenue [Member]", "terseLabel": "530 Seventh Avenue" } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Axis]", "documentation": "Information by contractual term of lease arrangement." } } }, "auth_ref": [ "r791" ] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Domain]", "documentation": "Contractual term of lease arrangement." } } }, "auth_ref": [ "r791" ] }, "us-gaap_LeaseExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseExpirationDate1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lease Expiration Date", "terseLabel": "Lease expiration date", "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r119" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r481" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r481" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Maturities of Lease Liabilities", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r870" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r485" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "verboseLabel": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r485" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "verboseLabel": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r485" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "verboseLabel": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r485" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "verboseLabel": "2024 (April 1 through December 31)", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r870" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: Discount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r485" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeases" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r477" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r21", "r185", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r422", "r425", "r426", "r457", "r604", "r677", "r709", "r830", "r872", "r873" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Current Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r101", "r141", "r549", "r696", "r811", "r824", "r868" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r23", "r157", "r185", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r422", "r425", "r426", "r457", "r696", "r830", "r872", "r873" ] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r18", "r89", "r90", "r91", "r94", "r185", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r422", "r425", "r426", "r457", "r830", "r872", "r873" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "verboseLabel": "Long-Term Liabilities:" } } }, "auth_ref": [] }, "xelb_LicenseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "LicenseAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to license agreement.", "label": "License Agreement [Member]", "terseLabel": "License Agreement" } } }, "auth_ref": [] }, "us-gaap_LicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicenseMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net licensing revenue", "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark." } } }, "auth_ref": [ "r837" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtAndOtherLongTermLiabilitiesNetCarryingAmountOfDebtDetailsCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt", "totalLabel": "Total", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r18", "r139", "r330", "r341", "r682", "r683", "r880" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtAndOtherLongTermLiabilitiesNetCarryingAmountOfDebtDetailsCalc2": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of debt", "verboseLabel": "Current portion of long-term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r162" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months", "verboseLabel": "2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r8", "r189", "r334" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four", "terseLabel": "2028", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r8", "r189", "r334" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three", "terseLabel": "2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r8", "r189", "r334" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two", "verboseLabel": "2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r8", "r189", "r334" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year", "verboseLabel": "2024 (April 1 through December 31)", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r812" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureDebtAndOtherLongTermLiabilitiesNetCarryingAmountOfDebtDetailsCalc2": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNetCarryingAmountOfDebtDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt, net, less current portion", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r163" ] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebt" ], "lang": { "en-us": { "role": { "label": "Long-term Debt [Text Block]", "verboseLabel": "Debt", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r122" ] }, "xelb_LongabergerLicensingLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "LongabergerLicensingLLCMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "documentation": "Longaberger Licensing, LLC [Member]", "label": "Longaberger Licensing, LLC" } } }, "auth_ref": [] }, "xelb_LoriGoldsteinBrandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "LoriGoldsteinBrandMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Lori Goldstein Brand.", "label": "Lori Goldstein Brand" } } }, "auth_ref": [] }, "xelb_LossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "LossFromEquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Loss From Equity Method Investments", "terseLabel": "Loss from equity method investment" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r238", "r688", "r836", "r881", "r882" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r364", "r531", "r565", "r596", "r597", "r654", "r655", "r656", "r657", "r660", "r666", "r667", "r679", "r686", "r691", "r698", "r834", "r874", "r875", "r876", "r877", "r878", "r879" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r752" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r752" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "label": "Minimum", "terseLabel": "Minimum" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r364", "r531", "r565", "r596", "r597", "r654", "r655", "r656", "r657", "r660", "r666", "r667", "r679", "r686", "r691", "r698", "r834", "r874", "r875", "r876", "r877", "r878", "r879" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r30", "r140", "r185", "r280", "r314", "r316", "r317", "r318", "r321", "r322", "r457", "r548", "r608" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Ownership interest", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r771" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r779" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "auth_ref": [ "r238", "r688", "r836", "r881", "r882" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r753" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r180" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r180" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "terseLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r112", "r113", "r114" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to Xcel Brands, Inc. stockholders", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r104", "r114", "r144", "r155", "r171", "r172", "r175", "r185", "r194", "r198", "r199", "r200", "r201", "r204", "r205", "r211", "r221", "r229", "r233", "r235", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r450", "r457", "r555", "r627", "r645", "r646", "r678", "r707", "r830" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net loss attributable to noncontrolling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r70", "r132", "r171", "r172", "r204", "r205", "r554", "r805" ] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r153", "r193", "r194", "r195", "r196", "r197", "r200", "r206", "r218", "r242", "r243", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r306", "r397", "r398", "r399", "r407", "r408", "r409", "r410", "r416", "r417", "r418", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r455", "r456", "r458", "r459", "r460", "r461", "r469", "r470", "r473", "r474", "r475", "r476", "r486", "r487", "r488", "r489", "r490", "r534", "r535", "r536", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r581" ] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items." } } }, "auth_ref": [ "r35", "r149", "r150", "r151", "r152", "r153", "r193", "r194", "r195", "r196", "r197", "r200", "r206", "r218", "r242", "r243", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r306", "r397", "r398", "r399", "r407", "r408", "r409", "r410", "r416", "r417", "r418", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r455", "r456", "r458", "r459", "r460", "r461", "r469", "r470", "r473", "r474", "r475", "r476", "r486", "r487", "r488", "r489", "r490", "r534", "r535", "r536", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r581" ] }, "xelb_NewLoanAndSecurityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "NewLoanAndSecurityAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureDebtXcelTermLoanRemainingPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to new loan and security agreement.", "label": "New Loan Agreement" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r752" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r722", "r733", "r743", "r760", "r768" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r750" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r749" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r760" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r779" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r779" ] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Additional royalty payments", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r11", "r57", "r131" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "verboseLabel": "Noncontrolling Interest", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r65", "r360", "r813", "r814", "r815", "r886" ] }, "xelb_NumberOfConsecutiveQuartersForRoyaltyPayableTerm": { "xbrltype": "integerItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "NumberOfConsecutiveQuartersForRoyaltyPayableTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of consecutive quarters for royalty payable term.", "label": "Number of Consecutive Quarters for Royalty Payable Term", "terseLabel": "Number of consecutive quarters for royalty payable term" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Operating loss", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r221", "r229", "r233", "r235", "r678" ] }, "us-gaap_OperatingIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLossAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other operating costs and expenses (income)" } } }, "auth_ref": [] }, "xelb_OperatingIncomeLossBeforeOtherExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "OperatingIncomeLossBeforeOtherExpense", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before the inclusion of other expenses.", "label": "Operating Income Loss Before Other Expense", "totalLabel": "Operating loss before other operating costs and expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r869" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "totalLabel": "Present value of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r479" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations", "verboseLabel": "Current portion of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r479" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current portion of lease liabilities", "verboseLabel": "Long-term portion of operating lease obligations", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r479" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Cash payments for operating lease expense", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r480", "r482" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r478" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r484", "r695" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term for operating leases", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r483", "r695" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Nature of Operations, Background, and Basis of Presentation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Nature of Operations, Background, and Basis of Presentation", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r79", "r129", "r579", "r580" ] }, "xelb_OrmeLiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "OrmeLiveMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to ORME Live, Inc. (\"ORME\").", "label": "ORME" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r160" ] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "xelb_OtherInterestAndFinanceChargesIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "OtherInterestAndFinanceChargesIncomeNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The amount of other interest and finance charges (income), net incurred during the period.", "label": "Other Interest And Finance Charges (Income) Net", "terseLabel": "Other interest and finance charges, net" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Other than Long-term Debt, Noncurrent", "verboseLabel": "Other long-term liabilities", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r26" ] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashExpense", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "label": "Other Noncash Expense", "terseLabel": "Non-cash expenses", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r114" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r752" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Other Receivables", "terseLabel": "Due from related party", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r167", "r614" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r720", "r731", "r741", "r766" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r723", "r734", "r744", "r769" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r723", "r734", "r744", "r769" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "xelb_OwnershipInterestTransferable": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "OwnershipInterestTransferable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting transferable should certain conditions be met.", "label": "Ownership Interest Transferable", "terseLabel": "Ownership equity transferable" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r748" ] }, "us-gaap_PaymentsForRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRoyalties", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Royalties", "terseLabel": "Payments for Royalties", "documentation": "The amount of cash paid for royalties during the current period." } } }, "auth_ref": [ "r3" ] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Equity Method Investments", "negatedLabel": "Capital contribution to equity method investees", "verboseLabel": "Members contribution", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r31" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r111" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r751" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r751" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r750" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r760" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r753" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r749" ] }, "xelb_PercentageOfNetCashFlowDistributableToMembers": { "xbrltype": "percentItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "PercentageOfNetCashFlowDistributableToMembers", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of net cash flow distributable to members.", "label": "Percentage of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members (in percent)" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r95", "r344" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized (in shares)", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r95", "r606" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued (in shares)", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r95", "r344" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding (in shares)", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r95", "r606", "r625", "r886", "r887" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r95", "r545", "r696" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r804" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "terseLabel": "Private Placement", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Net proceeds from the sale of shares", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Net proceeds from the sale of private placement shares", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance or Sale of Equity", "terseLabel": "Proceeds from public offering and private placement transactions, net of transaction costs", "verboseLabel": "Shares issued in connection with public offering and private placement transactions, net of transaction costs", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r2", "r583" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net sales", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r687" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r236", "r532", "r559", "r560", "r561", "r562", "r563", "r564", "r669", "r687", "r697", "r793", "r827", "r828", "r836", "r881" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r236", "r532", "r559", "r560", "r561", "r562", "r563", "r564", "r669", "r687", "r697", "r793", "r827", "r828", "r836", "r881" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net (loss) income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r155", "r171", "r172", "r179", "r185", "r194", "r204", "r205", "r221", "r229", "r233", "r235", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r420", "r423", "r424", "r450", "r457", "r540", "r553", "r593", "r627", "r645", "r646", "r678", "r693", "r694", "r708", "r805", "r830" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r7", "r541", "r550", "r696" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Type [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r119" ] }, "xelb_PublicOfferingAndPrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "PublicOfferingAndPrivatePlacementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "This member represents the public offering and private placement.", "label": "Public Offering and Private Placement" } } }, "auth_ref": [] }, "xelb_PublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "PublicOfferingMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "This member represents the public offering..", "label": "Public Offering [Member]", "terseLabel": "Public Offering" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r748" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r748" ] }, "xelb_QurateRetailGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "QurateRetailGroupMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Qurate Retail Group.", "label": "Qurate" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r363", "r364", "r391", "r392", "r393", "r507", "r531", "r565", "r596", "r597", "r654", "r655", "r656", "r657", "r660", "r666", "r667", "r679", "r686", "r691", "r698", "r701", "r825", "r834", "r875", "r876", "r877", "r878", "r879" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "auth_ref": [ "r310", "r311", "r312", "r313", "r363", "r364", "r391", "r392", "r393", "r507", "r531", "r565", "r596", "r597", "r654", "r655", "r656", "r657", "r660", "r666", "r667", "r679", "r686", "r691", "r698", "r701", "r825", "r834", "r875", "r876", "r877", "r878", "r879" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r715", "r726", "r736", "r761" ] }, "xelb_ReductionInOperatingExpensesOverNextYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ReductionInOperatingExpensesOverNextYear", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense for operating activities to be reduced over the next year. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Reduction in Operating Expenses Over Next Year", "terseLabel": "Reduction in operating expenses" } } }, "auth_ref": [] }, "xelb_ReductionInPayrollCostsOverNextYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ReductionInPayrollCostsOverNextYear", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees to be reduced over the next year. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Reduction in Payroll Costs Over the Next Year", "terseLabel": "Reduction in payroll costs" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r491", "r492", "r493", "r494", "r496", "r589", "r590", "r591", "r630", "r631", "r632", "r651", "r653" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r187", "r188", "r326", "r346", "r495", "r674", "r675" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r716", "r727", "r737", "r762" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r717", "r728", "r738", "r763" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r724", "r735", "r745", "r770" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash", "verboseLabel": "Restricted cash", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r33", "r135", "r158", "r183", "r544" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r36" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r98", "r126", "r547", "r572", "r577", "r587", "r607", "r696" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit [Member]", "verboseLabel": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r151", "r190", "r191", "r192", "r195", "r203", "r205", "r285", "r291", "r397", "r398", "r399", "r409", "r410", "r430", "r433", "r434", "r437", "r448", "r568", "r570", "r594", "r886" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net revenue", "verboseLabel": "Licensing revenue", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r222", "r223", "r228", "r231", "r232", "r236", "r237", "r238", "r361", "r362", "r532" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Revenues", "verboseLabel": "Revenue from services provided", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r176", "r185", "r222", "r223", "r228", "r231", "r232", "r236", "r237", "r238", "r280", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r457", "r540", "r830" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "auth_ref": [] }, "xelb_RightOfUseAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "RightOfUseAssetMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the right-of-use assets.", "label": "Right-Of-Use Asset [Member]", "terseLabel": "Right-of-use assets" } } }, "auth_ref": [] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Significant Contracts [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RoyaltyGuaranteesCommitmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RoyaltyGuaranteesCommitmentsAmount", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Royalty Guarantees, Commitments, Amount", "terseLabel": "Royalty guarantees", "verboseLabel": "Threshold royalties below which the equity interest would be transferable", "documentation": "The amount the entity has committed to make for future royalty guarantees." } } }, "auth_ref": [ "r538" ] }, "xelb_RoyaltyPayableTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "RoyaltyPayableTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of time that royalties will be payable.", "label": "Royalty Payable Term", "terseLabel": "Royalty payable term" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r779" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r779" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsQurateAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Sales [Member]", "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business." } } }, "auth_ref": [ "r16" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario, Unspecified [Domain]" } } }, "auth_ref": [ "r206", "r365", "r788", "r816" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r36" ] }, "xelb_ScheduleOfAssetAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ScheduleOfAssetAcquisitionLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule Of Asset Acquisition [Line Items]", "label": "Schedule Of Asset Acquisition [Line Items]" } } }, "auth_ref": [] }, "xelb_ScheduleOfAssetAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ScheduleOfAssetAcquisitionTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesInvestmentInOrmeLiveIncDetails", "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule of Asset Acquisition [Table]", "label": "Schedule Of Asset Acquisition [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]", "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]", "documentation": "Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability." } } }, "auth_ref": [ "r9", "r58", "r60", "r127" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of the basic and diluted net loss per share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r817" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r276", "r277", "r279" ] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "verboseLabel": "Schedule of Trademarks and Other Intangibles", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-Term Debt", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r366", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "verboseLabel": "Summary of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r13", "r14", "r61" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Activity", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r50", "r51", "r52", "r53", "r54", "r55", "r56", "r124", "r125", "r126", "r164", "r165", "r166", "r220", "r344", "r345", "r346", "r348", "r351", "r356", "r358", "r583", "r584", "r585", "r586", "r686", "r786", "r809" ] }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "terseLabel": "Summary of Stock Option Activity for Non-Vested Options", "documentation": "Tabular disclosure of the change in stock options." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "verboseLabel": "Summary of Warrant Activity", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r59" ] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r865" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r710" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r712" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "verboseLabel": "Other selling, general and administrative expenses", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r109" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "xelb_ServiceFeesReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ServiceFeesReduction", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "A reduction in a fee charged by the company in relation to services performed.", "label": "Service Fees, Reduction", "terseLabel": "Reduction in service fees" } } }, "auth_ref": [] }, "xelb_ServicesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ServicesAgreementMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Services Agreement.", "label": "Services Agreement [Member]", "terseLabel": "Services Agreement" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation", "verboseLabel": "Stock-based compensation and cost of licensee warrants", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Other disclosures" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Expired/Forfeited (in shares)", "negatedTerseLabel": "Forfeitures of restricted stock grants", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r385" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r383" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r383" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r380", "r381" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Other than Options", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r380", "r381" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)", "verboseLabel": "Number of shares vested", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r384" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r384" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stockholders' Equity", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r366", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of common stock eligible for issuance", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r692" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "verboseLabel": "Shares are granted available for issuance (in shares)", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r60" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable (in shares)", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r374" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercisable (in dollars per share)", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r374" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Expired/Forfeited (in shares)", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r844" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired/Forfeited (in dollars per share)", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r844" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r376" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r60" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r372", "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r372", "r373" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockUnitsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r377" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Granted (in dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r376" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Share Price", "terseLabel": "Common stock price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Aggregate Intrinsic Value, Exercisable", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r60" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable Weighted Average Remaining Contractual Life (in Years)", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r60" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Options", "verboseLabel": "Number of Options", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance (in dollars per share)", "periodStartLabel": "Beginning Balance (in dollars per share)", "documentation": "Weighted average grant-date fair value of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "verboseLabel": "Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Outstanding Weighted Average Remaining Contractual Life (in Years)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r128" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Share price", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Balances (in shares)", "periodStartLabel": "Balances (in shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r29", "r151", "r173", "r174", "r175", "r190", "r191", "r192", "r195", "r203", "r205", "r219", "r285", "r291", "r360", "r397", "r398", "r399", "r409", "r410", "r430", "r432", "r433", "r434", "r435", "r437", "r448", "r462", "r463", "r464", "r465", "r466", "r467", "r490", "r568", "r569", "r570", "r594", "r647" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "verboseLabel": "Contract Terms", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r190", "r191", "r192", "r219", "r532", "r582", "r595", "r598", "r599", "r600", "r601", "r602", "r603", "r606", "r609", "r610", "r611", "r612", "r613", "r615", "r616", "r617", "r618", "r620", "r621", "r622", "r623", "r624", "r626", "r628", "r629", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r647", "r702" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r206", "r365", "r788", "r789", "r816" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r190", "r191", "r192", "r219", "r532", "r582", "r595", "r598", "r599", "r600", "r601", "r602", "r603", "r606", "r609", "r610", "r611", "r612", "r613", "r615", "r616", "r617", "r618", "r620", "r621", "r622", "r623", "r624", "r626", "r628", "r629", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r647", "r702" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r719", "r730", "r740", "r765" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Shares issued in connection with stock grant", "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Shares issued to consultant in connection with stock grant (in shares)", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r12", "r126" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Shares issued in connection with stock grant (in shares)", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Shares issued on exercises of stock options, net of shares surrendered for cashless exercises (in shares)", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r12", "r95", "r96", "r126", "r377" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Shares issued to consultant in connection with stock grant", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r12", "r95", "r96", "r126" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued on exercises of stock options, net of shares surrendered for cashless exercises", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r12", "r29", "r126" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Xcel Brands, Inc. stockholders' equity", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r96", "r99", "r100", "r116", "r608", "r625", "r648", "r649", "r696", "r709", "r811", "r824", "r868", "r886" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' Equity:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balances", "periodStartLabel": "Balances", "totalLabel": "Total Stockholders' Equity", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r65", "r66", "r69", "r151", "r152", "r174", "r190", "r191", "r192", "r195", "r203", "r285", "r291", "r360", "r397", "r398", "r399", "r409", "r410", "r430", "r432", "r433", "r434", "r435", "r437", "r448", "r462", "r463", "r467", "r490", "r569", "r570", "r592", "r608", "r625", "r648", "r649", "r661", "r708", "r811", "r824", "r868", "r886" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholders' Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r123", "r184", "r343", "r345", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r357", "r360", "r439", "r650", "r652", "r662" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r468", "r499" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r468", "r499" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r468", "r499" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r468", "r499" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r468", "r499" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Event" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r498", "r500" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Supplemental disclosure of cash flow information:" } } }, "auth_ref": [] }, "us-gaap_SwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SwapMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Swap [Member]", "terseLabel": "Swap contract with IDB", "documentation": "A forward-based contract in which two parties agree to swap streams of payments over a specified period. The payment streams are based on an agreed-upon (or notional) principal amount. The term notional is used because swap contracts generally involve no exchange of principal at either inception or maturity. Rather, the notional amount serves as a basis for calculation of the payment streams to be exchanged." } } }, "auth_ref": [ "r133", "r613", "r618", "r623", "r638", "r644", "r658", "r659", "r701" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r759" ] }, "xelb_ThresholdAmountOfNetCashFlowDistributableToMembers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "ThresholdAmountOfNetCashFlowDistributableToMembers", "crdr": "credit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold amount of net cash flow distributable to members.", "label": "Threshold Amount of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r818", "r871" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsFinancingTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Relationship to Entity [Domain]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r751" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r758" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks (finite-lived)", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r64" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r778" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r780" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r339", "r356", "r438", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r556", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r819", "r820", "r821", "r822" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r781" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r782" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r780" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r780" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r783" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r781" ] }, "xelb_TwelveMonthPeriodEndingMarch312025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "TwelveMonthPeriodEndingMarch312025Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining twelve-month period ending March 31, 2025", "label": "Twelve-month period ending March 31, 2025" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesSaleOfMajorityInterestInIsaacMizrahiBrandInvestmentInImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsImTopcoLlcLicenseAgreementDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r419" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r777" ] }, "xelb_UnexercisedStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "UnexercisedStockOptionsMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information relating to unexercised stock options.", "label": "Unexercised Stock Options" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityOwnershipPercentage", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)." } } }, "auth_ref": [ "r68" ] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureInvestmentsInUnconsolidatedAffiliatesAndVariableInterestEntitiesLongabergerLicensingLlcVieDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Primary Beneficiary", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r67", "r421", "r422", "r425", "r426" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants", "terseLabel": "Warrants", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r699", "r700", "r703", "r704", "r705", "r706" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsHalsonMasterLicenseDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityPublicOfferingAndPrivatePlacementTransactionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r867" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted average number of shares outstanding", "verboseLabel": "Diluted weighted average common shares outstanding", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r209", "r214" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic weighted average number of shares outstanding", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r208", "r214" ] }, "xelb_WorkingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "WorkingCapitalNet", "crdr": "debit", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityAndManagementSPlansDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of net of current asset and liabilities.", "label": "Working Capital, Net", "terseLabel": "Working capital, Net" } } }, "auth_ref": [] }, "xelb_YearEndingDecember312025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.xcelbrands.com/20240331", "localname": "YearEndingDecember312025Member", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining year ending December 31, 2025,", "label": "Year ending December 31, 2025" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "44", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482943/710-10-55-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "83", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480647/815-10-15-83" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "323", "Publisher": "FASB", "URI": "https://asc.fasb.org//323/tableOfContent" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483119/928-440-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r697": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r699": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r701": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r707": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r708": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r709": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r710": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r711": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r712": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r714": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r715": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r716": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r732": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r733": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r734": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r735": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r736": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r737": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r738": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r739": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r740": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r741": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r742": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r743": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r744": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r745": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r746": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r748": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r749": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r750": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r751": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r752": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r753": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r754": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r755": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r756": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r757": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r758": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r759": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r760": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r761": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r762": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r763": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r764": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r765": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r766": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r786": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r787": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "323", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2" }, "r788": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r789": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r819": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r820": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r821": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r822": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r823": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r824": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r825": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r826": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 76 0001558370-24-008490-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-008490-xbrl.zip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�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end XML 78 xelb-20240331x10q_htm.xml IDEA: XBRL DOCUMENT 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2024-04-12 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-11-01 2023-11-30 0001083220 xelb:HalstonBrandMember srt:MinimumMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember srt:MaximumMember 2023-05-15 2023-05-15 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 2022-05-31 0001083220 2023-01-01 2023-12-31 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2024-04-12 2024-04-12 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 2022-05-31 0001083220 xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-12 2024-04-12 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-30 0001083220 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2021-04-01 2021-04-01 0001083220 2024-02-16 2024-02-16 0001083220 xelb:LoriGoldsteinBrandMember 2024-01-01 2024-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2023-01-01 2023-12-31 0001083220 xelb:LoriGoldsteinBrandMember 2022-01-01 2022-12-31 0001083220 xelb:Lease1113BroadwayMember 2024-01-26 2024-01-26 0001083220 xelb:Lease530SeventhAvenueMember 2024-02-29 2024-02-29 0001083220 xelb:Lease1113BroadwayMember 2024-01-01 2024-03-31 0001083220 xelb:HalstonBrandMember 2023-05-15 2023-05-15 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember xelb:HilcoGlobalMember 2024-01-01 2024-03-31 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember 2024-01-01 2024-03-31 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001083220 xelb:ConsultantsMember 2023-01-01 2023-03-31 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001083220 xelb:ConsultantsMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2024-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2024-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001083220 us-gaap:RetainedEarningsMember 2023-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001083220 us-gaap:RetainedEarningsMember 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2022-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001083220 xelb:ConsultantsMember us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001083220 xelb:ConsultantsMember 2024-01-01 2024-03-31 0001083220 us-gaap:CommonStockMember 2024-03-31 0001083220 us-gaap:CommonStockMember 2023-12-31 0001083220 us-gaap:CommonStockMember 2023-03-31 0001083220 us-gaap:CommonStockMember 2022-12-31 0001083220 us-gaap:PrivatePlacementMember 2024-03-14 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2024-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-12-31 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-05-15 2023-05-15 0001083220 xelb:ConsultantMember 2024-01-12 2024-01-12 0001083220 xelb:IMTopcoLLCMember xelb:YearEndingDecember312025Member us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember xelb:TwelveMonthPeriodEndingMarch312025Member us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-03-31 0001083220 srt:MaximumMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2024-01-01 2024-03-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001083220 xelb:HalstonBrandMember 2024-01-01 2024-03-31 0001083220 us-gaap:LicenseMember 2024-01-01 2024-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001083220 us-gaap:ProductMember 2023-01-01 2023-03-31 0001083220 us-gaap:LicenseMember 2023-01-01 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001083220 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001083220 xelb:PublicOfferingAndPrivatePlacementMember 2024-03-15 2024-03-15 0001083220 2024-03-01 2024-03-31 0001083220 us-gaap:CommonStockMember xelb:PublicOfferingAndPrivatePlacementMember 2024-01-01 2024-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember xelb:PublicOfferingAndPrivatePlacementMember 2024-01-01 2024-03-31 0001083220 xelb:PublicOfferingAndPrivatePlacementMember 2024-01-01 2024-03-31 0001083220 us-gaap:PrivatePlacementMember 2024-03-14 2024-03-14 0001083220 xelb:PublicOfferingMember 2024-03-19 2024-03-19 0001083220 xelb:OrmeLiveMember 2023-12-01 2023-12-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2022-05-31 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-03-31 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-11-01 2023-11-30 0001083220 xelb:OrmeLiveMember 2024-03-31 0001083220 xelb:IMTopcoLLCMember 2024-03-31 0001083220 xelb:OrmeLiveMember 2023-12-31 0001083220 xelb:IMTopcoLLCMember 2022-05-31 0001083220 xelb:IMTopcoLLCMember 2023-07-01 2023-09-30 0001083220 xelb:OrmeLiveMember 2024-01-01 2024-03-31 0001083220 xelb:Lease1113BroadwayMember xelb:RightOfUseAssetMember 2024-02-29 2024-02-29 0001083220 xelb:Lease1113BroadwayMember us-gaap:LeaseholdImprovementsMember 2024-01-01 2024-03-31 0001083220 xelb:IMTopcoLLCMember 2024-01-01 2024-03-31 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-03-31 0001083220 us-gaap:TrademarksMember 2024-03-31 0001083220 us-gaap:IntellectualPropertyMember 2024-03-31 0001083220 us-gaap:TrademarksMember 2023-12-31 0001083220 us-gaap:IntellectualPropertyMember 2023-12-31 0001083220 xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember xelb:ImWhpLlcMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMember us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember us-gaap:SubsequentEventMember 2024-04-12 0001083220 xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2024-03-31 0001083220 xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-27 0001083220 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2024-03-31 0001083220 us-gaap:SwapMember 2023-10-19 0001083220 us-gaap:SwapMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember xelb:IsraelDiscountBankOfNewYorkMember 2023-10-19 0001083220 xelb:HalstonBrandMember 2024-03-31 0001083220 xelb:HalstonBrandMember 2023-12-31 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-10-19 2023-10-19 0001083220 xelb:NewLoanAndSecurityAgreementMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-10-19 0001083220 xelb:NewLoanAndSecurityAgreementMember 2024-03-31 0001083220 xelb:NewLoanAndSecurityAgreementMember 2023-10-19 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001083220 xelb:HalstonBrandMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001083220 xelb:PublicOfferingMember 2024-03-19 0001083220 xelb:PublicOfferingMember 2024-03-15 0001083220 us-gaap:CommonStockMember xelb:PublicOfferingAndPrivatePlacementMember 2024-03-31 0001083220 us-gaap:RestrictedStockMember 2024-03-31 0001083220 srt:ExecutiveVicePresidentMember xelb:PublicOfferingMember 2024-03-19 0001083220 srt:DirectorMember xelb:PublicOfferingMember 2024-03-19 0001083220 srt:ChiefExecutiveOfficerMember xelb:PublicOfferingMember 2024-03-19 0001083220 xelb:PublicOfferingAndPrivatePlacementMember 2024-03-15 0001083220 xelb:AgreementsMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:ExecutiveVicePresidentMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:DirectorMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 srt:ChiefExecutiveOfficerMember us-gaap:PrivatePlacementMember 2024-03-14 0001083220 us-gaap:RestrictedStockMember 2023-12-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2021Member 2024-03-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2011Member 2024-03-31 0001083220 xelb:EquityIncentivePlan2021Member 2024-03-31 0001083220 us-gaap:WarrantMember 2024-03-31 0001083220 us-gaap:WarrantMember 2023-12-31 0001083220 us-gaap:WarrantMember 2024-03-19 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember 2023-05-15 0001083220 2022-12-31 0001083220 2023-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2023-12-31 0001083220 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001083220 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001083220 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001083220 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001083220 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001083220 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001083220 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001083220 2024-03-31 0001083220 2023-12-31 0001083220 2024-05-01 0001083220 2024-01-01 2024-03-31 shares iso4217:USD iso4217:USD shares pure xelb:item -0.31 -0.29 20374920 19633194 0001083220 --12-31 2024 Q1 false 0 0 23452117 19795053 P6Y P4Y1M17D P4Y6M P25Y 10-Q true 2024-03-31 false 001-37527 XCEL BRANDS, INC. DE 76-0307819 550 Seventh Avenue, 11th Floor New York NY 10018 347 727-2474 Common Stock, $0.001 par value per share XELB NASDAQ Yes Yes Non-accelerated Filer true false false 23492117 1552000 2998000 75000 3603000 3454000 445000 453000 471000 398000 6071000 7303000 133000 634000 2535000 4453000 39986000 41520000 17070000 17585000 969000 165000 60693000 64357000 66764000 71660000 1918000 2236000 889000 889000 372000 372000 1278000 1258000 1000000 750000 723000 964000 6180000 6469000 3333000 3556000 3694000 4021000 3747000 3971000 5432000 5432000 506000 40000 16712000 17020000 22892000 23489000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 50000000 50000000 23452117 19795053 23000 20000 105904000 103861000 -60143000 -53849000 45784000 50032000 -1912000 -1861000 43872000 48171000 66764000 71660000 2184000 2222000 3828000 2184000 6050000 2693000 2184000 3357000 1933000 3465000 2029000 3493000 3962000 6958000 -1778000 -3601000 1589000 1797000 2295000 533000 515000 -6195000 -5913000 146000 4000 25000 -150000 -25000 -6345000 -5938000 -6345000 -5938000 -51000 -295000 -6294000 -5643000 -0.31 -0.29 20374920 19633194 19624860 20000 103592000 -32797000 -676000 70139000 51000 51000 8334 6000 6000 -5643000 -295000 -5938000 19633194 20000 103649000 -38440000 -971000 64258000 19795053 20000 103861000 -53849000 -1861000 48171000 36000 36000 10000 10000 78000 98000 98000 3579064 3000 1899000 1902000 -6294000 -51000 -6345000 23452117 23000 105904000 -60143000 -1912000 43872000 -6345000 -5938000 1589000 1797000 2295000 26000 144000 57000 -533000 -515000 149000 859000 -8000 254000 156000 -425000 -223000 240000 -560000 1156000 -237000 -54000 466000 -2609000 -2915000 81000 -81000 1902000 1902000 -707000 -2996000 2998000 4608000 2291000 1612000 1552000 1612000 739000 2291000 1612000 119000 16000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">1. Nature of Operations, Background, and Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands. </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand are wholly owned by the Company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company manages the Longaberger Brand through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch by the end of May 2024.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Management’s Plans  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. The Company had working capital (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in common stock) of approximately $2.1 million as of March 31, 2024. The Company’s unrestricted cash and cash equivalents were approximately $1.6 million as of March 31, 2024. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 0.50 0.30 0.30 -6300000 4600000 -60100000 -2600000 2100000 1600000 6000000 9000000 5000000 1900000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">2.      Investments in Unconsolidated Affiliates and Variable Interest Entities  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Investment in IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold </span><span style="font-weight:normal;">70%</span><span style="font-weight:normal;"> of the membership interests of IM Topco to WHP. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its 30% interest in the ongoing operations of IM Topco as other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">first, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to WHP, until WHP has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$8,852,000 </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(subject to adjustment in certain circumstances as set forth in the agreement); </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">second, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,316,200</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (subject to adjustment in certain circumstances as set forth in the agreement); and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">thereafter, in proportion to the members’ respective percentage interests.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million related to its investment in IM Topco for each of the three-month periods ended March 31, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for both of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal Xcel’s share of amortization expense.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three months ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (437)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (437)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Refer to Notes 10, 11, and 12 for other information regarding the Company’s ongoing relationship with IM Topco.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Investment in Orme Live, Inc.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s condensed consolidated balance sheets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three months ended March 31, 2024 was a loss of approximately $0.02 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Longaberger Licensing, LLC Variable Interest Entity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.</p> 0.70 0.30 1 8852000 1 1316200 -520000 0.70 0.30 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the three months ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;width:35.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:16.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,752</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (437)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr><tr><td style="vertical-align:bottom;width:62.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (437)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr></table> 2752000 3346000 2752000 3346000 -437000 -143000 -437000 -143000 150000 0.30 0.30 20000.00 0.50 0.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">3.      Trademarks and Other Intangibles   </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Trademarks and other intangibles, net consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 39,930</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 56</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 29,323</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 39,986</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,431</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,449</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 358</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,789</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 41,520</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Amortization expense for intangible assets was approximately $1.53 million for the three-month period ended March 31, 2024 (the "current quarter") and approximately $1.54 million for the three-month period ended March 31, 2023 (the "prior year quarter"). </p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 28,950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 39,930</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 373</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 56</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 29,323</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 39,986</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:41.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 27,431</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 41,449</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 358</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 71</p></td></tr><tr><td style="vertical-align:bottom;width:42.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 27,789</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 41,520</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> P15Y 68880000 28950000 39930000 P8Y 429000 373000 56000 69309000 29323000 39986000 P15Y 68880000 27431000 41449000 P8Y 429000 358000 71000 69309000 27789000 41520000 1530000 1540000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">4.      Significant Contracts and Concentrations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Qurate Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Net licensing revenue from the Qurate Agreements totaled $1.61 million and $1.52 million for the current quarter and prior year quarter, respectively, representing approximately 59% and 25% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of March 31, 2024 and December 31, 2023, the Company had receivables from Qurate of $1.3 million and $1.5 million, respectively, representing approximately 37% and 43% of the Company’s total net accounts receivable, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Halston Master License</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a </span><span style="font-style:normal;font-weight:normal;">twenty-five-year</span><span style="font-style:normal;font-weight:normal;"> term (consisting of an initial </span><span style="font-style:normal;font-weight:normal;">five-year</span><span style="font-style:normal;font-weight:normal;"> period, followed by a </span><span style="font-style:normal;font-weight:normal;">twenty-year</span><span style="font-style:normal;font-weight:normal;"> period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each </span><span style="font-style:normal;font-weight:normal;">five-year</span><span style="font-style:normal;font-weight:normal;"> period during the term. G-III has an option to purchase the Halston Brand for </span><span style="font-style:normal;font-weight:normal;">$5.0</span><span style="font-style:normal;font-weight:normal;"> million at the end of the </span><span style="-sec-ix-hidden:Hidden_uovuGnB-wEa6Kv8tl9P5Kg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five-year</span></span><span style="font-style:normal;font-weight:normal;"> term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized </span><span style="font-style:normal;font-weight:normal;">$4.2</span><span style="font-style:normal;font-weight:normal;"> million and </span><span style="font-style:normal;font-weight:normal;">$4.4</span><span style="font-style:normal;font-weight:normal;"> million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. As of December 31, 2023, </span><span style="font-style:normal;font-weight:normal;">$0.9</span><span style="font-style:normal;font-weight:normal;"> million of the contract liability balance was classified as a current liability and approximately </span><span style="font-style:normal;font-weight:normal;">$3.5</span><span style="font-style:normal;font-weight:normal;"> million was classified as a long-term liability. As of March 31, 2024, </span><span style="font-style:normal;font-weight:normal;">$0.9</span><span style="font-style:normal;font-weight:normal;"> million of the contract liability balance was classified as a current liability and approximately </span><span style="font-style:normal;font-weight:normal;">$3.3</span><span style="font-style:normal;font-weight:normal;"> million was classified as a long-term liability. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next </span><span style="-sec-ix-hidden:Hidden_A9m4isXhwEC87S2aeF8BQA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.13 years</span></span><span style="font-style:normal;font-weight:normal;">. Net licensing revenue recognized from the Halston Master License was </span><span style="font-style:normal;font-weight:normal;">$0.6</span><span style="font-style:normal;font-weight:normal;"> million for the current quarter, representing approximately </span><span style="font-style:normal;font-weight:normal;">30%</span><span style="font-style:normal;font-weight:normal;"> of the Company’s total net revenue for the current quarter.</span></p> 1610000 1520000 0.59 0.25 1300000 1500000 0.37 0.43 P25Y P5Y P20Y P5Y 5000000.0 4200000 4400000 900000 3500000 900000 3300000 600000 0.30 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">5. Leases </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Lease expense (net of sublease income) included in selling, general and administrative expenses on the Company’s condensed consolidated statements of operations was approximately $0.2 million and $0.4 million for the current quarter and prior year quarter, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">1333 Broadway </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized a non-cash impairment charge of approximately $1.9 million effective February 29, 2024 (which was determined to be the date of a fundamental change to the use of the 1333 Broadway premises) related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the current quarter related to leasehold improvement assets at this location.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of March 31, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.58 years, and the lease liability recorded on the Company’s condensed consolidated balance sheet is measured using a discount rate of 6.25%. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">550 Seventh Avenue</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year. As of March 31, 2024, no right-of-use asset or lease liability was recorded in the Company’s condensed consolidated balance sheet related to this lease, as the lease had not yet commenced.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Future Lease Obligations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of March 31, 2024, the maturities of lease obligations were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024 (April 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,164</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,294</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,562</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">590</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,972</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,278</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3,694</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 200000 400000 400000 400000 2027-10-30 1300000 800000 1900000 400000 P3Y6M29D 0.0625 500000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024 (April 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,164</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,552</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,294</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,562</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">590</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4,972</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,278</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3,694</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 1164000 1552000 1552000 1294000 5562000 590000 4972000 1278000 3694000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">6. Debt</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company’s net carrying amount of debt was comprised of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unamortized deferred finance costs related to term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (253)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (279)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of March 31, 2024, the aggregate remaining principal payments under the term loan were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount of</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Payment</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024 (April 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of March 31, 2024 and December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For the current quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.15 million, reflecting an effective interest rate of approximately 11.6%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unamortized deferred finance costs related to term loan debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (253)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (279)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Long-term debt</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,747</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 5000000 5000000 253000 279000 4747000 4721000 1000000 750000 3747000 3971000 5000000.0 300000 250000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount of</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Principal</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year Ending December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Payment</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024 (April 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 750</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,000</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,250</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,000</p></td></tr></table> 750000 1000000 1000000 1000000 1250000 5000000 0.0425 0.0425 0.0946 150000 0.116 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:9.35pt;text-indent:-9.35pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:9.25pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">7.</b></span><b style="font-weight:bold;white-space:pre-wrap;"> Stockholders’ Equity </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Public Offering and Private Placement Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of </span><span style="font-style:normal;font-weight:normal;">3,284,422</span><span style="font-style:normal;font-weight:normal;"> shares of the Company’s common stock at a price to the public of </span><span style="font-style:normal;font-weight:normal;">$0.65</span><span style="font-style:normal;font-weight:normal;"> per share. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately </span><span style="font-style:normal;font-weight:normal;">$1.7</span><span style="font-style:normal;font-weight:normal;"> million.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to </span><span style="font-style:normal;font-weight:normal;">182,952</span><span style="font-style:normal;font-weight:normal;"> shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of </span><span style="font-style:normal;font-weight:normal;">$0.8125</span><span style="font-style:normal;font-weight:normal;">. The Representative’s Warrants are exercisable, in whole or in part, during the </span><span style="-sec-ix-hidden:Hidden_ofnGaPj2M0yaekmL53xXKw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">four and one-half-year period</span></span><span style="font-style:normal;font-weight:normal;"> commencing 180 days from the commencement of sales of the shares of common stock in the Offering.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase </span><span style="font-style:normal;font-weight:normal;">132,589</span><span style="font-style:normal;font-weight:normal;">, </span><span style="font-style:normal;font-weight:normal;">132,589</span><span style="font-style:normal;font-weight:normal;">, and </span><span style="font-style:normal;font-weight:normal;">29,464</span><span style="font-style:normal;font-weight:normal;"> shares, respectively (collectively, the “Private Placement Shares”), at a price of </span><span style="font-style:normal;font-weight:normal;">$0.98</span><span style="font-style:normal;font-weight:normal;"> per Private Placement Share. The total number of Private Placement Shares purchased was </span><span style="font-style:normal;font-weight:normal;">294,642</span><span style="font-style:normal;font-weight:normal;">. Net proceeds after payment of agent fees to the Representative were approximately </span><span style="font-style:normal;font-weight:normal;">$0.3</span><span style="font-style:normal;font-weight:normal;"> million. The purchase of the Private Placement Shares closed concurrently with the Offering.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The aggregate number of shares of common stock issued from the Offering and the Private Placement was </span><span style="font-style:normal;font-weight:normal;">3,579,064</span><span style="font-style:normal;font-weight:normal;"> shares and the total net proceeds received was approximately </span><span style="font-style:normal;font-weight:normal;">$1.9</span><span style="font-style:normal;font-weight:normal;"> million.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock-based Compensation </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total expense recognized for all forms of stock-based compensation was approximately $0.13 million and $0.06 million for the current quarter and prior year quarter, respectively. For both periods, substantially all of the expense was related to directors and consultants, and was recorded as operating costs within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s stock options activity for the current quarter is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,148,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (259,500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at March 31, 2024, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,889,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,139,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.78</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.03 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2024 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.97 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s non-vested stock options activity for the current quarter is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Stock Awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s restricted stock activity for the current quarter is as follows:  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.69</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 78,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.25</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (78,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.25</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.69</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which shares vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Compensation expense related to stock awards was approximately $0.11 million for the current quarter and approximately $0.03 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2024 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 0.96 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Restricted Stock Units</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">There were no restricted stock units outstanding as of March 31, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Available Under the Company’s Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">At March 31, 2024, there were 3,025,941 shares of common stock available for future award grants under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Reserved for Issuance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of March 31, 2024, there were 8,031,046 shares of common stock reserved for issuance, including 4,511,755 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,025,941 shares available for issuance under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s warrants activity for the current quarter is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Issued</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 182,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,299,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">Warrants issued during the current quarter were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was </span><span style="font-style:normal;font-weight:normal;">no</span><span style="font-style:normal;font-weight:normal;"> compensation expense recognized during the current quarter related to these warrants. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">In connection with the entrance into the Halston Master License (see Note 4), the Company issued to G-III a </span><span style="font-style:normal;font-weight:normal;">ten-year</span><span style="font-style:normal;font-weight:normal;"> warrant to purchase up to </span><span style="font-style:normal;font-weight:normal;">1,000,000</span><span style="font-style:normal;font-weight:normal;"> shares of the Company’s common stock at an exercise price of </span><span style="font-style:normal;font-weight:normal;">$1.50</span><span style="font-style:normal;font-weight:normal;"> per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the current quarter was approximately </span><span style="font-style:normal;font-weight:normal;">$0.01</span><span style="font-style:normal;font-weight:normal;"> million. As of March 31, 2024, </span><span style="font-style:normal;font-weight:normal;">no</span><span style="font-style:normal;font-weight:normal;"> portion of this warrant had vested.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in the current quarter or prior year quarter.</p> 3284422 0.65 1700000 182952 0.8125 132589 132589 29464 0.98 294642 300000 3579064 1900000 4000000 130000 60000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,148,540</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.03</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (259,500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at March 31, 2024, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,889,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.91</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,139,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.78</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> 5148540 2.03 P4Y3M3D 0 0 0 0 0 259500 4.21 4889040 1.91 P4Y2M26D 0 1139040 2.58 P1Y9M10D 0 20000.00 30000.00 50000.00 P0Y11M19D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,750,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr></table> 3750000 0.05 3750000 0.05 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.69</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 78,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.25</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (78,000)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.25</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.69</p></td></tr></table> 333333 3.69 78000 1.25 78000 1.25 0 0 333333 3.69 78000 110000 30000.00 40000.00 P0Y11M15D 0 0 0 0 3025941 8031046 4511755 493350 3025941 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at January 1, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.67</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8.46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Issued</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 182,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,299,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at March 31, 2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.30</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr></table> 1116065 1.67 P8Y5M15D 0 182952 0.81 0 0 0 0 1299017 1.55 P7Y9M 0 116065 3.15 P0Y3M18D 0 0 P10Y 1000000 1.50 10000.00 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10.1pt;text-indent:-10.1pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">8.    Earnings (Loss) Per Share</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the three months ended March 31, 2024 and 2023:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:32.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:34.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,294)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,643)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,374,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,374,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share for such periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,889,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,368,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,299,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,188,057</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,484,845</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:32.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:34.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6,294)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (5,643)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,374,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 20,374,920</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Diluted net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> -6294000 -5643000 20374920 19633194 20374920 19633194 -0.31 -0.29 -0.31 -0.29 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,889,040</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,368,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,299,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,188,057</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,484,845</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 4889040 5368780 1299017 116065 6188057 5484845 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">9.    Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.</p> 0 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">10.    Related Party Transactions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Service Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company recognized service fee income related to this agreement of $37,500 and $75,000 for the current quarter and prior year quarter, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">License Agreement</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the prior year quarter, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. No amounts were paid to IM Topco during the current quarter, and as of March 31, 2024, the remaining payments due totaled $375,000. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Financing Transactions</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><i style="font-style:italic;">Public Offering and Private Placement Transactions</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 7 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 300000 600000 37500 75000 400000 60000 450000 450000 0 375000 3284422 0.65 146250 146250 32500 0.65 132589 132589 29464 0.98 294642 300000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">11.    Commitments and Contingencies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Isaac Mizrahi Transaction</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Lori Goldstein Earn-Out</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the <span style="-sec-ix-hidden:Hidden_UWk3QB5lek6A17vmzif4Mg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">six</span></span> calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Legal Matters</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As of the filing date of this Quarterly Report on Form 10-Q, there have been no definitive agreements or terms agreed to by the parties, and it is not certain when or if an agreement will be executed.</p> 13300000 4 P3Y 16000000 12500000 6600000 200000 200000 1000000.0 300000 1000000.0 700000 5400000 963642 241000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">12.    Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">IM Topco</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 (and as subsequently amended) membership purchase agreement and the related business venture agreement. Under these amendments, the parties agreed to the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If IM Topco royalties are less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$13.5</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the twelve-month period ending March 31, 2025 or less than </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$18.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">12.5%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">17.5%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, and WHP’s ownership interest in IM Topco would increase from </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">70%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">82.5%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco by October 10, 2024 under the second amendment (which totaled </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$375,000</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> as of December 31, 2023 and March 31, 2024). In April 2024, Xcel paid </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$100,000</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of this amount to WHP.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">On and after January 1, 2026, WHP shall receive </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1.0</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million.  </span></td></tr></table><div style="margin-top:12pt;"></div> 13500000 18000000.0 0.125 0.30 0.175 0.70 0.825 375000 100000 0.50 1000000.0 false false false false